<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33803907</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>21</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Mar</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle><i>Pseudomonas aeruginosa</i>: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">3128</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22063128</ELocationID>
        <Abstract>
          <AbstractText><i>Pseudomonas aeruginosa</i> is a dominant pathogen in people with cystic fibrosis (CF) contributing to morbidity and mortality. Its tremendous ability to adapt greatly facilitates its capacity to cause chronic infections. The adaptability and flexibility of the pathogen are afforded by the extensive number of virulence factors it has at its disposal, providing <i>P. aeruginosa</i> with the facility to tailor its response against the different stressors in the environment. A deep understanding of these virulence mechanisms is crucial for the design of therapeutic strategies and vaccines against this multi-resistant pathogen. Therefore, this review describes the main virulence factors of <i>P. aeruginosa</i> and the adaptations it undergoes to persist in hostile environments such as the CF respiratory tract. The very large <i>P. aeruginosa</i> genome (5 to 7 MB) contributes considerably to its adaptive capacity; consequently, genomic studies have provided significant insights into elucidating <i>P. aeruginosa</i> evolution and its interactions with the host throughout the course of infection.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Jurado-Martín</LastName>
            <ForeName>Irene</ForeName>
            <Initials>I</Initials>
            <Identifier Source="ORCID">0000-0002-5433-5389</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin 4 D04 V1W8, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sainz-Mejías</LastName>
            <ForeName>Maite</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-4254-1900</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin 4 D04 V1W8, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McClean</LastName>
            <ForeName>Siobhán</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-6389-2542</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Biomolecular and Biomedical Sciences, University College Dublin, Belfield, Dublin 4 D04 V1W8, Ireland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000222" MajorTopicYN="Y">Adaptation, Physiological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018441" MajorTopicYN="N">Biofilms</DescriptorName>
          <QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011550" MajorTopicYN="N">Pseudomonas aeruginosa</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053038" MajorTopicYN="N">Quorum Sensing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Pseudomonas aeruginosa</Keyword>
        <Keyword MajorTopicYN="N">adaptation</Keyword>
        <Keyword MajorTopicYN="N">cystic fibrosis</Keyword>
        <Keyword MajorTopicYN="N">diversity</Keyword>
        <Keyword MajorTopicYN="N">genomics</Keyword>
        <Keyword MajorTopicYN="N">lung environment</Keyword>
        <Keyword MajorTopicYN="N">virulence factors</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest. The funders had no role in the writing of the manuscript, or in the content of the review.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>3</Day>
          <Hour>1</Hour>
          <Minute>15</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33803907</ArticleId>
        <ArticleId IdType="pmc">PMC8003266</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms22063128</ArticleId>
        <ArticleId IdType="pii">ijms22063128</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Riquelme S.A., Liimatta K., Wong Fok Lung T., Fields B., Ahn D., Chen D., Lozano C., Sáenz Y., Uhlemann A.C., Kahl B.C., et al.  Pseudomonas aeruginosa Utilizes Host-Derived Itaconate to Redirect Its Metabolism to Promote Biofilm Formation. Cell Metab. 2020;31:1091–1106. doi: 10.1016/j.cmet.2020.04.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2020.04.017</ArticleId>
            <ArticleId IdType="pmc">PMC7272298</ArticleId>
            <ArticleId IdType="pubmed">32428444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernández-Barat L., Ferrer M., De Rosa F., Gabarrús A., Esperatti M., Terraneo S., Rinaudo M., Li Bassi G., Torres A. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance. J. Infect. 2017;74:142–152. doi: 10.1016/j.jinf.2016.11.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2016.11.008</ArticleId>
            <ArticleId IdType="pubmed">27865895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wunderink R.G., Waterer G. Advances in the causes and management of community acquired pneumonia in adults. BMJ. 2017;358:j2471. doi: 10.1136/bmj.j2471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.j2471</ArticleId>
            <ArticleId IdType="pubmed">28694251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Nuñez M., Marti S., Puig C., Perez-Brocal V., Millares L., Santos S., Ardanuy C., Moya A., Liñares J., Monsó E. Bronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa. Future Microbiol. 2017;12:379–392. doi: 10.2217/fmb-2016-0127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2217/fmb-2016-0127</ArticleId>
            <ArticleId IdType="pubmed">28339291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winstanley C., O’Brien S., Brockhurst M.A. Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections. Trends Microbiol. 2016;24:327–337. doi: 10.1016/j.tim.2016.01.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2016.01.008</ArticleId>
            <ArticleId IdType="pmc">PMC4854172</ArticleId>
            <ArticleId IdType="pubmed">26946977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubes J.N., Fridkin S.K. Factors affecting the geographic variability of antibiotic-resistant healthcare-associated infections in the United States using the CDC Antibiotic Resistance Patient Safety Atlas. Infect. Control. Hosp. Epidemiol. 2019;40:597–599. doi: 10.1017/ice.2019.64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/ice.2019.64</ArticleId>
            <ArticleId IdType="pubmed">30975229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiehlmann L., Wagner G., Cramer N., Siebert B., Gudowius P., Morales G., Köhler T., van Delden C., Weinel C., Slickers P., et al.  Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA. 2007;104:8101–8106. doi: 10.1073/pnas.0609213104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0609213104</ArticleId>
            <ArticleId IdType="pmc">PMC1876578</ArticleId>
            <ArticleId IdType="pubmed">17468398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>World Health Organization  . Guidelines for the Prevention and Control of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities. World Health Organization; Geneva, Switzerland: 2017. </Citation>
        </Reference>
        <Reference>
          <Citation>Tacconelli E., Carrara E., Savoldi A., Harbarth S., Mendelson M., Monnet D.L., Pulcini C., Kahlmeter G., Kluytmans J., Carmeli Y., et al.  Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 2018;18:318–327. doi: 10.1016/S1473-3099(17)30753-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(17)30753-3</ArticleId>
            <ArticleId IdType="pubmed">29276051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Botelho J., Grosso F., Peixe L. Antibiotic resistance in Pseudomonas aeruginosa—Mechanisms, epidemiology and evolution. Drug Resist. Updat. 2019;44:100640. doi: 10.1016/j.drup.2019.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.drup.2019.07.002</ArticleId>
            <ArticleId IdType="pubmed">31492517</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moradali M.F., Ghods S., Rehm B.H. Lifestyle: A Paradigm for Adaptation, Survival, and Persistence. Front. Cell Infect. Microbiol. 2017;7:39. doi: 10.3389/fcimb.2017.00039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2017.00039</ArticleId>
            <ArticleId IdType="pmc">PMC5310132</ArticleId>
            <ArticleId IdType="pubmed">28261568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maurice N.M., Bedi B., Sadikot R.T. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections. Am. J. Respir. Cell Mol. Biol. 2018;58:428–439. doi: 10.1165/rcmb.2017-0321TR.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2017-0321TR</ArticleId>
            <ArticleId IdType="pmc">PMC5894500</ArticleId>
            <ArticleId IdType="pubmed">29372812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Francis V.I., Stevenson E.C., Porter S.L. Two-component systems required for virulence in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 2017;364 doi: 10.1093/femsle/fnx104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/femsle/fnx104</ArticleId>
            <ArticleId IdType="pmc">PMC5812489</ArticleId>
            <ArticleId IdType="pubmed">28510688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sainz-Mejías M., Jurado-Martín I., McClean S. Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine. Cells. 2020;9:2617.  doi: 10.3390/cells9122617.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells9122617</ArticleId>
            <ArticleId IdType="pmc">PMC7762141</ArticleId>
            <ArticleId IdType="pubmed">33291484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riquelme S.A., Ahn D., Prince A. Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung. J. Innate Immun. 2018;10:442–454. doi: 10.1159/000487515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000487515</ArticleId>
            <ArticleId IdType="pmc">PMC6785651</ArticleId>
            <ArticleId IdType="pubmed">29617698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elborn J.S. Cystic fibrosis. Lancet. 2016;388:2519–2531. doi: 10.1016/S0140-6736(16)00576-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)00576-6</ArticleId>
            <ArticleId IdType="pubmed">27140670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riquelme S.A., Hopkins B.D., Wolfe A.L., DiMango E., Kitur K., Parsons R., Prince A. Cystic Fibrosis Transmembrane Conductance Regulator Attaches Tumor Suppressor PTEN to the Membrane and Promotes Anti Pseudomonas aeruginosa Immunity. Immunity. 2017;47:1169–1181. doi: 10.1016/j.immuni.2017.11.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2017.11.010</ArticleId>
            <ArticleId IdType="pmc">PMC5738266</ArticleId>
            <ArticleId IdType="pubmed">29246444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reece E., Segurado R., Jackson A., McClean S., Renwick J., Greally P. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: An Irish registry analysis. BMC Pulm. Med. 2017;17:70.  doi: 10.1186/s12890-017-0416-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12890-017-0416-4</ArticleId>
            <ArticleId IdType="pmc">PMC5401475</ArticleId>
            <ArticleId IdType="pubmed">28431569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cigana C., Lorè N.I., Riva C., De Fino I., Spagnuolo L., Sipione B., Rossi G., Nonis A., Cabrini G., Bragonzi A. Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections. Sci. Rep. 2016;6:21465. doi: 10.1038/srep21465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep21465</ArticleId>
            <ArticleId IdType="pmc">PMC4756310</ArticleId>
            <ArticleId IdType="pubmed">26883959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D’Argenio D.A., Miller S.I., Ramsey B.W., Speert D.P., Moskowitz S.M., et al.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. USA. 2006;103:8487–8492. doi: 10.1073/pnas.0602138103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0602138103</ArticleId>
            <ArticleId IdType="pmc">PMC1482519</ArticleId>
            <ArticleId IdType="pubmed">16687478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jimenez P.N., Koch G., Thompson J.A., Xavier K.B., Cool R.H., Quax W.J. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 2012;76:46–65. doi: 10.1128/MMBR.05007-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MMBR.05007-11</ArticleId>
            <ArticleId IdType="pmc">PMC3294424</ArticleId>
            <ArticleId IdType="pubmed">22390972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balasubramanian D., Schneper L., Kumari H., Mathee K. A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 2013;41:1–20. doi: 10.1093/nar/gks1039.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gks1039</ArticleId>
            <ArticleId IdType="pmc">PMC3592444</ArticleId>
            <ArticleId IdType="pubmed">23143271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Montor W.R., Huang J., Hu Y., Hainsworth E., Lynch S., Kronish J.W., Ordonez C.L., Logvinenko T., Lory S., LaBaer J. Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays. Infect. Immun. 2009;77:4877–4886. doi: 10.1128/IAI.00698-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00698-09</ArticleId>
            <ArticleId IdType="pmc">PMC2772540</ArticleId>
            <ArticleId IdType="pubmed">19737893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Remans K., Vercammen K., Bodilis J., Cornelis P. Genome-wide analysis and literature-based survey of lipoproteins in Pseudomonas aeruginosa. Microbiology. 2010;156:2597–2607. doi: 10.1099/mic.0.040659-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.040659-0</ArticleId>
            <ArticleId IdType="pubmed">20616104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bianconi I., Alcalá-Franco B., Scarselli M., Dalsass M., Buccato S., Colaprico A., Marchi S., Masignani V., Bragonzi A. Genome-Based Approach Delivers Vaccine Candidates Against Pseudomonas aeruginosa. Front. Immunol. 2018;9:3021. doi: 10.3389/fimmu.2018.03021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2018.03021</ArticleId>
            <ArticleId IdType="pmc">PMC6334337</ArticleId>
            <ArticleId IdType="pubmed">30687303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pang Z., Raudonis R., Glick B.R., Lin T.J., Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies. Biotechnol. Adv. 2019;37:177–192. doi: 10.1016/j.biotechadv.2018.11.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biotechadv.2018.11.013</ArticleId>
            <ArticleId IdType="pubmed">30500353</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maldonado R.F., Sá-Correia I., Valvano M.A. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol. Rev. 2016;40:480–493. doi: 10.1093/femsre/fuw007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/femsre/fuw007</ArticleId>
            <ArticleId IdType="pmc">PMC4931227</ArticleId>
            <ArticleId IdType="pubmed">27075488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huszczynski S.M., Lam J.S., Khursigara C.M. The Role of Pseudomonas aeruginosa Lypopolisaccharide in Bacterial Pathogenesis and Phisiology. Pathogens. 2019;9:6.  doi: 10.3390/pathogens9010006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pathogens9010006</ArticleId>
            <ArticleId IdType="pmc">PMC7168646</ArticleId>
            <ArticleId IdType="pubmed">31861540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King J.D., Kocíncová D., Westman E.L., Lam J.S. Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immun. 2009;15:261–312. doi: 10.1177/1753425909106436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1753425909106436</ArticleId>
            <ArticleId IdType="pubmed">19710102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan F., Li W., Jono H., Li Q., Zhang S., Li J.D., Shen H. Reactive oxygen species regulate Pseudomonas aeruginosa lipopolysaccharide-induced MUC5AC mucin expression via PKC-NADPH oxidase-ROS-TGF-alpha signaling pathways in human airway epithelial cells. Biochem. Biophys. Res. Commun. 2008;366:513–519. doi: 10.1016/j.bbrc.2007.11.172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2007.11.172</ArticleId>
            <ArticleId IdType="pubmed">18073139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li W., Yan F., Zhou H., Lin X., Wu Y., Chen C., Zhou N., Chen Z., Li J.D., Shen H.P. aeruginosa lipopolysaccharide-induced MUC5AC and CLCA3 expression is partly through Duox1 in vitro and in vivo. PLoS ONE. 2013;8:e63945.  doi: 10.1371/journal.pone.0063945.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0063945</ArticleId>
            <ArticleId IdType="pmc">PMC3653940</ArticleId>
            <ArticleId IdType="pubmed">23691121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eutamene H., Theodorou V., Schmidlin F., Tondereau V., Garcia-Villar R., Salvador-Cartier C., Chovet M., Bertrand C., Bueno L. LPS-induced lung inflammation is linked to increased epithelial permeability: Role of MLCK. Eur. Respir. J. 2005;25:789–796. doi: 10.1183/09031936.05.00064704.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.05.00064704</ArticleId>
            <ArticleId IdType="pubmed">15863634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wieland C.W., Siegmund B., Senaldi G., Vasil M.L., Dinarello C.A., Fantuzzi G. Pulmonary inflammation induced by Pseudomonas aeruginosa lipopolysaccharide, phospholipase C, and exotoxin A: Role of interferon regulatory factor 1. Infect. Immun. 2002;70:1352–1358. doi: 10.1128/IAI.70.3.1352-1358.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.70.3.1352-1358.2002</ArticleId>
            <ArticleId IdType="pmc">PMC127789</ArticleId>
            <ArticleId IdType="pubmed">11854220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lam J.S., Taylor V.L., Islam S.T., Hao Y., Kocíncová D. Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide. Front. Microbiol. 2011;2:118. doi: 10.3389/fmicb.2011.00118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2011.00118</ArticleId>
            <ArticleId IdType="pmc">PMC3108286</ArticleId>
            <ArticleId IdType="pubmed">21687428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park B.S., Lee J.O. Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp. Mol. Med. 2013;45:e66. doi: 10.1038/emm.2013.97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/emm.2013.97</ArticleId>
            <ArticleId IdType="pmc">PMC3880462</ArticleId>
            <ArticleId IdType="pubmed">24310172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Florez C., Raab J.E., Cooke A.C., Schertzer J.W. Membrane Distribution of the Pseudomonas Quinolone Signal Modulates Outer Membrane Vesicle Production in Pseudomonas aeruginosa. mBio. 2017;8 doi: 10.1128/mBio.01034-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.01034-17</ArticleId>
            <ArticleId IdType="pmc">PMC5550756</ArticleId>
            <ArticleId IdType="pubmed">28790210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alshalchi S.A., Anderson G.G. Expression of the lipopolysaccharide biosynthesis gene lpxD affects biofilm formation of Pseudomonas aeruginosa. Arch. Microbiol. 2015;197:135–145. doi: 10.1007/s00203-014-1030-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00203-014-1030-y</ArticleId>
            <ArticleId IdType="pubmed">25173672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pieterse E., Rother N., Yanginlar C., Hilbrands L.B., van der Vlag J. Neutrophils Discriminate between Lipopolysaccharides of Different Bacterial Sources and Selectively Release Neutrophil Extracellular Traps. Front. Immunol. 2016;7:484. doi: 10.3389/fimmu.2016.00484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2016.00484</ArticleId>
            <ArticleId IdType="pmc">PMC5095130</ArticleId>
            <ArticleId IdType="pubmed">27867387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy K., Park A.J., Hao Y., Brewer D., Lam J.S., Khursigara C.M. Influence of O polysaccharides on biofilm development and outer membrane vesicle biogenesis in Pseudomonas aeruginosa PAO1. J. Bacteriol. 2014;196:1306–1317. doi: 10.1128/JB.01463-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01463-13</ArticleId>
            <ArticleId IdType="pmc">PMC3993350</ArticleId>
            <ArticleId IdType="pubmed">24464462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindhout T., Lau P.C.Y., Brewer D., Lam J.S. Truncation in the core oligosaccharide of lipopolysaccharide affects flagella-mediated motility in Pseudomonas aeruginosa PAO1 via modulation of cell surface attachment. Microbiology. 2009;155:3449–3460. doi: 10.1099/mic.0.030510-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.030510-0</ArticleId>
            <ArticleId IdType="pubmed">19589832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jamasbi R.J., Taylor N.M. Correlation Between the Lipopolysaccharide Expression and Adhesiveness of Clinical Isolates of Pseudomonas aeruginosa. Lab. Med. 2010;41:24–30. doi: 10.1309/LM2UYWSOBDJWHYSU.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1309/LM2UYWSOBDJWHYSU</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chevalier S., Bouffartigues E., Bodilis J., Maillot O., Lesouhaitier O., Feuilloley M.G.J., Orange N., Dufour A., Cornelis P. Structure, function and regulation of Pseudomonas aeruginosa porins. FEMS Microbiol. Rev. 2017;41:698–722. doi: 10.1093/femsre/fux020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/femsre/fux020</ArticleId>
            <ArticleId IdType="pubmed">28981745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cassin E.K., Tseng B.S. Pushing beyond the Envelope: The Potential Roles of OprF in Pseudomonas aeruginosa Biofilm Formation and Pathogenicity. J. Bacteriol. 2019;201:e00050-19. doi: 10.1128/JB.00050-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00050-19</ArticleId>
            <ArticleId IdType="pmc">PMC6707909</ArticleId>
            <ArticleId IdType="pubmed">31010902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Navare A.T., Chavez J.D., Zheng C., Weisbrod C.R., Eng J.K., Siehnel R., Singh P.K., Manoil C., Bruce J.E. Probing the protein interaction network of Pseudomonas aeruginosa cells by chemical cross-linking mass spectrometry. Structure. 2015;23:762–773. doi: 10.1016/j.str.2015.01.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.str.2015.01.022</ArticleId>
            <ArticleId IdType="pmc">PMC4756656</ArticleId>
            <ArticleId IdType="pubmed">25800553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fito-Boncompte L., Chapalain A., Bouffartigues E., Chaker H., Lesouhaitier O., Gicquel G., Bazire A., Madi A., Connil N., Véron W., et al.  Full virulence of Pseudomonas aeruginosa requires OprF. Infect. Immun. 2011;79:1176–1186. doi: 10.1128/IAI.00850-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00850-10</ArticleId>
            <ArticleId IdType="pmc">PMC3067511</ArticleId>
            <ArticleId IdType="pubmed">21189321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bukhari S.I., Aleanizy F.S. Association of OprF mutant and disturbance of biofilm and pyocyanin virulence in Pseudomonas aeruginosa. Saudi Pharm. J. 2020;28:196–200. doi: 10.1016/j.jsps.2019.11.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsps.2019.11.021</ArticleId>
            <ArticleId IdType="pmc">PMC7000307</ArticleId>
            <ArticleId IdType="pubmed">32042258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McClean S. Eight stranded B-barrel and related outer membrane proteins: Role in bacterial pathogenesis. Protein Pept. Lett. 2012;19:1013–1025. doi: 10.2174/092986612802762688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/092986612802762688</ArticleId>
            <ArticleId IdType="pubmed">22533621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song F., Wang H., Sauer K., Ren D. Cyclic-di-GMP and OprF Are Involved in the Response of Pseudomonas aeruginosa to Substrate Material Stiffness during Attachment on Polydimethylsiloxane (PDMS) Front. Microbiol. 2018;9:110. doi: 10.3389/fmicb.2018.00110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2018.00110</ArticleId>
            <ArticleId IdType="pmc">PMC5799285</ArticleId>
            <ArticleId IdType="pubmed">29449837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouffartigues E., Moscoso J.A., Duchesne R., Rosay T., Fito-Boncompte L., Gicquel G., Maillot O., Bénard M., Bazire A., Brenner-Weiss G., et al.  The absence of the Pseudomonas aeruginosa OprF protein leads to increased biofilm formation through variation in c-di-GMP level. Front. Microbiol. 2015;6:630. doi: 10.3389/fmicb.2015.00630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2015.00630</ArticleId>
            <ArticleId IdType="pmc">PMC4477172</ArticleId>
            <ArticleId IdType="pubmed">26157434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garai P., Berry L., Moussouni M., Bleves S., Blanc-Potard A.B. Killing from the inside: Intracellular role of T3SS in the fate of Pseudomonas aeruginosa within macrophages revealed by mgtC and OprF mutants. PLoS Pathog. 2019;15:e1007812.  doi: 10.1371/journal.ppat.1007812.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1007812</ArticleId>
            <ArticleId IdType="pmc">PMC6586356</ArticleId>
            <ArticleId IdType="pubmed">31220187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra M., Ressler A., Schlesinger L.S., Wozniak D.J. Identification of OprF as a complement component C3 binding acceptor molecule on the surface of Pseudomonas aeruginosa. Infect. Immun. 2015;83:3006–3014. doi: 10.1128/IAI.00081-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00081-15</ArticleId>
            <ArticleId IdType="pmc">PMC4496607</ArticleId>
            <ArticleId IdType="pubmed">25964476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moussouni M., Berry L., Sipka T., Nguyen-Chi M., Blanc-Potard A.B. Pseudomonas aeruginosa OprF plays a role in resistance to macrophage clearance during acute infection. Sci. Rep. 2021;11:359. doi: 10.1038/s41598-020-79678-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-79678-0</ArticleId>
            <ArticleId IdType="pmc">PMC7801371</ArticleId>
            <ArticleId IdType="pubmed">33432030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qadi M., Lopez-Causapé C., Izquierdo-Rabassa S., Mateu Borrás M., Goldberg J.B., Oliver A., Albertí S. Surfactant Protein A Recognizes Outer Membrane Protein OprH on Pseudomonas aeruginosa Isolates from Individuals With Chronic Infection. J. Infect. Dis. 2016;214:1449–1455. doi: 10.1093/infdis/jiw387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiw387</ArticleId>
            <ArticleId IdType="pubmed">27543671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Paulsson M., Su Y.C., Ringwood T., Uddén F., Riesbeck K. Pseudomonas aeruginosa uses multiple receptors for adherence to laminin during infection of the respiratory tract and skin wounds. Sci. Rep. 2019;9:18168. doi: 10.1038/s41598-019-54622-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-54622-z</ArticleId>
            <ArticleId IdType="pmc">PMC6890786</ArticleId>
            <ArticleId IdType="pubmed">31796854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arhin A., Boucher C. The outer membrane protein OprQ and adherence of Pseudomonas aeruginosa to human fibronectin. Microbiology. 2010;156:1415–1423. doi: 10.1099/mic.0.033472-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.033472-0</ArticleId>
            <ArticleId IdType="pubmed">20093292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panmanee W., Gomez F., Witte D., Pancholi V., Britigan B.E., Hassett D.J. The peptidoglycan-associated lipoprotein OprL helps protect a Pseudomonas aeruginosa mutant devoid of the transactivator OxyR from hydrogen peroxide-mediated killing during planktonic and biofilm culture. J. Bacteriol. 2008;190:3658–3669. doi: 10.1128/JB.00022-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00022-08</ArticleId>
            <ArticleId IdType="pmc">PMC2395008</ArticleId>
            <ArticleId IdType="pubmed">18310335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Auda I.G., Ali Salman I.M., Auda J.G. Efflux pumps of Gram-negative bacteria in brief. Gene Rep. 2020;20 doi: 10.1016/j.genrep.2020.100666.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.genrep.2020.100666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kucharska I., Liang B., Ursini N., Tamm L.K. Molecular Interactions of Lipopolysaccharide with an Outer Membrane Protein from Pseudomonas aeruginosa Probed by Solution NMR. Biochemistry. 2016;55:5061–5072. doi: 10.1021/acs.biochem.6b00630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.biochem.6b00630</ArticleId>
            <ArticleId IdType="pmc">PMC5441840</ArticleId>
            <ArticleId IdType="pubmed">27532487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J., Patel D.S., Kucharska I., Tamm L.K., Im W. Refinement of OprH-LPS Interactions by Molecular Simulations. Biophys. J. 2017;112:346–355. doi: 10.1016/j.bpj.2016.12.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bpj.2016.12.006</ArticleId>
            <ArticleId IdType="pmc">PMC5266143</ArticleId>
            <ArticleId IdType="pubmed">28122220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee K., Yoon S.S. Pseudomonas aeruginosa Biofilm, a Programmed Bacterial Life for Fitness. J. Microbiol. Biotechnol. 2017;27:1053–1064. doi: 10.4014/jmb.1611.11056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4014/jmb.1611.11056</ArticleId>
            <ArticleId IdType="pubmed">28301918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan S., Wu G. Can Biofilm Be Reversed Through Quorum Sensing in Pseudomonas aeruginosa? Front. Microbiol. 2019;10:1582. doi: 10.3389/fmicb.2019.01582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2019.01582</ArticleId>
            <ArticleId IdType="pmc">PMC6664025</ArticleId>
            <ArticleId IdType="pubmed">31396166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mann E.E., Wozniak D.J. Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol. Rev. 2012;36:893–916. doi: 10.1111/j.1574-6976.2011.00322.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6976.2011.00322.x</ArticleId>
            <ArticleId IdType="pmc">PMC4409827</ArticleId>
            <ArticleId IdType="pubmed">22212072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei Q., Ma L.Z. Biofilm matrix and its regulation in Pseudomonas aeruginosa. Int. J. Mol. Sci. 2013;14:20983–21005. doi: 10.3390/ijms141020983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms141020983</ArticleId>
            <ArticleId IdType="pmc">PMC3821654</ArticleId>
            <ArticleId IdType="pubmed">24145749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenau F., Isenhardt S., Gdynia A., Tielker D., Schmidt E., Tielen P., Schobert M., Jahn D., Wilhelm S., Jaeger K.E. Lipase LipC affects motility, biofilm formation and rhamnolipid production in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 2010;309:25–34. doi: 10.1111/j.1574-6968.2010.02017.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6968.2010.02017.x</ArticleId>
            <ArticleId IdType="pubmed">20546309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tielen P., Rosenau F., Wilhelm S., Jaeger K.E., Flemming H.C., Wingender J. Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa. Microbiology. 2010;156:2239–2252. doi: 10.1099/mic.0.037036-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.037036-0</ArticleId>
            <ArticleId IdType="pubmed">20360178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilhelm S., Gdynia A., Tielen P., Rosenau F., Jaeger K.E. The autotransporter esterase EstA of Pseudomonas aeruginosa is required for rhamnolipid production, cell motility, and biofilm formation. J. Bacteriol. 2007;189:6695–6703. doi: 10.1128/JB.00023-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00023-07</ArticleId>
            <ArticleId IdType="pmc">PMC2045186</ArticleId>
            <ArticleId IdType="pubmed">17631636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tielen P., Kuhn H., Rosenau F., Jaeger K.E., Flemming H.C., Wingender J. Interaction between extracellular lipase LipA and the polysaccharide alginate of Pseudomonas aeruginosa. BMC Microbiol. 2013;13:159.  doi: 10.1186/1471-2180-13-159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2180-13-159</ArticleId>
            <ArticleId IdType="pmc">PMC3733896</ArticleId>
            <ArticleId IdType="pubmed">23848942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooke A.C., Florez C., Dunshee E.B., Lieber A.D., Terry M.L., Light C.J., Schertzer J.W. Quinolone Signal-Induced Outer Membrane Vesicles Enhance Biofilm Dispersion in Pseudomonas aeruginosa. mSphere. 2020;5:e01109-20. doi: 10.1128/mSphere.01109-20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mSphere.01109-20</ArticleId>
            <ArticleId IdType="pmc">PMC7690959</ArticleId>
            <ArticleId IdType="pubmed">33239369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller C.L., Romero M., Karna S.L., Chen T., Heeb S., Leung K.P. RsmW, Pseudomonas aeruginosa small non-coding RsmA-binding RNA upregulated in biofilm versus planktonic growth conditions. BMC Microbiol. 2016;16:155.  doi: 10.1186/s12866-016-0771-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12866-016-0771-y</ArticleId>
            <ArticleId IdType="pmc">PMC4950607</ArticleId>
            <ArticleId IdType="pubmed">27430253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thöming J.G., Tomasch J., Preusse M., Koska M., Grahl N., Pohl S., Willger S.D., Kaever V., Müsken M., Häussler S. Parallel evolutionary paths to produce more than one Pseudomonas aeruginosa biofilm phenotype. NPJ Biofilms Microbiomes. 2020;6:2. doi: 10.1038/s41522-019-0113-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41522-019-0113-6</ArticleId>
            <ArticleId IdType="pmc">PMC6954232</ArticleId>
            <ArticleId IdType="pubmed">31934344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cross A.R., Raghuram V., Wang Z., Dey D., Goldberg J.B. Overproduction of the AlgT Sigma Factor Is Lethal to Mucoid Pseudomonas aeruginosa. J. Bacteriol. 2020;202:e00445-20. doi: 10.1128/JB.00445-20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00445-20</ArticleId>
            <ArticleId IdType="pmc">PMC7515251</ArticleId>
            <ArticleId IdType="pubmed">32747430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryder C., Byrd M., Wozniak D.J. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr. Opin. Microbiol. 2007;10:644–648. doi: 10.1016/j.mib.2007.09.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mib.2007.09.010</ArticleId>
            <ArticleId IdType="pmc">PMC2176169</ArticleId>
            <ArticleId IdType="pubmed">17981495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghafoor A., Hay I.D., Rehm B.H. Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture. Appl. Environ. Microbiol. 2011;77:5238–5246. doi: 10.1128/AEM.00637-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.00637-11</ArticleId>
            <ArticleId IdType="pmc">PMC3147449</ArticleId>
            <ArticleId IdType="pubmed">21666010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orgad O., Oren Y., Walker S.L., Herzberg M. The role of alginate in Pseudomonas aeruginosa EPS adherence, viscoelastic properties and cell attachment. Biofouling. 2011;27:787–798. doi: 10.1080/08927014.2011.603145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08927014.2011.603145</ArticleId>
            <ArticleId IdType="pubmed">21797737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strateva T., Mitov I. Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections Ann. Microbiol. 2011;61:717–732. doi: 10.1007/s13213-011-0273-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13213-011-0273-y</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leid J.G., Willson C.J., Shirtliff M.E., Hassett D.J., Parsek M.R., Jeffers A.K. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J. Immunol. 2005;175:7512–7518. doi: 10.4049/jimmunol.175.11.7512.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.175.11.7512</ArticleId>
            <ArticleId IdType="pubmed">16301659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rybtke M., Jensen P., Nielsen C.H., Tolker-Nielsen T. The Extracellular Polysaccharide Matrix of Pseudomonas aeruginosa Biofilms Is a Determinant of Polymorphonuclear Leukocyte Responses. Infect. Immun. 2020;89:e00631-20. doi: 10.1128/IAI.00631-20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00631-20</ArticleId>
            <ArticleId IdType="pmc">PMC7927924</ArticleId>
            <ArticleId IdType="pubmed">33077623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goltermann L., Tolker-Nielsen T. Importance of the Exopolysaccharide Matrix in Antimicrobial Tolerance of Pseudomonas aeruginosa Aggregates. Antimicrob. Agents Chemother. 2017;61 doi: 10.1128/AAC.02696-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.02696-16</ArticleId>
            <ArticleId IdType="pmc">PMC5365683</ArticleId>
            <ArticleId IdType="pubmed">28137803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haiko J., Westerlund-Wikström B. The role of the bacterial flagellum in adhesion and virulence. Biology. 2013;2:1242–1267. doi: 10.3390/biology2041242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/biology2041242</ArticleId>
            <ArticleId IdType="pmc">PMC4009794</ArticleId>
            <ArticleId IdType="pubmed">24833223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sampedro I., Parales R.E., Krell T., Hill J.E. Pseudomonas chemotaxis. FEMS Microbiol. Rev. 2015;39:17–46. doi: 10.1111/1574-6976.12081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1574-6976.12081</ArticleId>
            <ArticleId IdType="pubmed">25100612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song W.S., Yoon S.I. Crystal structure of FliC flagellin from Pseudomonas aeruginosa and its implication in TLR5 binding and formation of the flagellar filament. Biochem. Biophys. Res. Commun. 2014;444:109–115. doi: 10.1016/j.bbrc.2014.01.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2014.01.008</ArticleId>
            <ArticleId IdType="pubmed">24434155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwarzer C., Fischer H., Machen T.E. Chemotaxis and Binding of Pseudomonas aeruginosa to Scratch-Wounded Human Cystic Fibrosis Airway Epithelial Cells. PLoS ONE. 2016;11:e0150109.  doi: 10.1371/journal.pone.0150109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0150109</ArticleId>
            <ArticleId IdType="pmc">PMC4816407</ArticleId>
            <ArticleId IdType="pubmed">27031335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duan Q., Zhou M., Zhu L., Zhu G. Flagella and bacterial pathogenicity. J. Basic Microbiol. 2013;53:1–8. doi: 10.1002/jobm.201100335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jobm.201100335</ArticleId>
            <ArticleId IdType="pubmed">22359233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bucior I., Pielage J.F., Engel J.N. Pseudomonas aeruginosa pili and flagella mediate distinct binding and signaling events at the apical and basolateral surface of airway epithelium. PLoS Pathog. 2012;8:e1002616.  doi: 10.1371/journal.ppat.1002616.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1002616</ArticleId>
            <ArticleId IdType="pmc">PMC3320588</ArticleId>
            <ArticleId IdType="pubmed">22496644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ketko A.K., Lin C., Moore B.B., LeVine A.M. Surfactant protein A binds flagellin enhancing phagocytosis and IL-1β production. PLoS ONE. 2013;8:e82680.  doi: 10.1371/journal.pone.0082680.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0082680</ArticleId>
            <ArticleId IdType="pmc">PMC3846784</ArticleId>
            <ArticleId IdType="pubmed">24312669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang S., McCormack F.X., Levesque R.C., O’Toole G.A., Lau G.W. The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A. PLoS ONE. 2007;2:e564.  doi: 10.1371/journal.pone.0000564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0000564</ArticleId>
            <ArticleId IdType="pmc">PMC1891440</ArticleId>
            <ArticleId IdType="pubmed">17593964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guttenplan S.B., Kearns D.B. Regulation of flagellar motility during biofilm formation. FEMS Microbiol. Rev. 2013;37:849–871. doi: 10.1111/1574-6976.12018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1574-6976.12018</ArticleId>
            <ArticleId IdType="pmc">PMC3718880</ArticleId>
            <ArticleId IdType="pubmed">23480406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jacobsen T., Bardiaux B., Francetic O., Izadi-Pruneyre N., Nilges M. Structure and function of minor pilins of type IV pili. Med. Microbiol. Immunol. 2020;209:301–308. doi: 10.1007/s00430-019-00642-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00430-019-00642-5</ArticleId>
            <ArticleId IdType="pmc">PMC7248040</ArticleId>
            <ArticleId IdType="pubmed">31784891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horna G., Quezada K., Ramos S., Mosqueda N., Rubio M., Guerra H., Ruiz J. Specific type IV pili groups in clinical isolates of Pseudomonas aeruginosa. Int. Microbiol. 2019;22:131–141. doi: 10.1007/s10123-018-00035-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10123-018-00035-3</ArticleId>
            <ArticleId IdType="pubmed">30810940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burrows L.L. Pseudomonas aeruginosa twitching motility: Type IV pili in action. Annu. Rev. Microbiol. 2012;66:493–520. doi: 10.1146/annurev-micro-092611-150055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-micro-092611-150055</ArticleId>
            <ArticleId IdType="pubmed">22746331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talà L., Fineberg A., Kukura P., Persat A. Pseudomonas aeruginosa orchestrates twitching motility by sequential control of type IV pili movements. Nat. Microbiol. 2019;4:774–780. doi: 10.1038/s41564-019-0378-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41564-019-0378-9</ArticleId>
            <ArticleId IdType="pmc">PMC6522360</ArticleId>
            <ArticleId IdType="pubmed">30804544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heiniger R.W., Winther-Larsen H.C., Pickles R.J., Koomey M., Wolfgang M.C. Infection of human mucosal tissue by Pseudomonas aeruginosa requires sequential and mutually dependent virulence factors and a novel pilus-associated adhesin. Cell Microbiol. 2010;12:1158–1173. doi: 10.1111/j.1462-5822.2010.01461.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-5822.2010.01461.x</ArticleId>
            <ArticleId IdType="pmc">PMC2906647</ArticleId>
            <ArticleId IdType="pubmed">20331639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson M.D., Garrett C.K., Bond J.E., Coggan K.A., Wolfgang M.C., Redinbo M.R. Pseudomonas aeruginosa PilY1 binds integrin in an RGD- and calcium-dependent manner. PLoS ONE. 2011;6:e29629.  doi: 10.1371/journal.pone.0029629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0029629</ArticleId>
            <ArticleId IdType="pmc">PMC3248442</ArticleId>
            <ArticleId IdType="pubmed">22242136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siryaporn A., Kuchma S.L., O’Toole G.A., Gitai Z. Surface attachment induces Pseudomonas aeruginosa virulence. Proc. Natl. Acad. Sci. USA. 2014;111:16860–16865. doi: 10.1073/pnas.1415712111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1415712111</ArticleId>
            <ArticleId IdType="pmc">PMC4250119</ArticleId>
            <ArticleId IdType="pubmed">25385640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marko V.A., Kilmury S.L.N., MacNeil L.T., Burrows L.L. Pseudomonas aeruginosa type IV minor pilins and PilY1 regulate virulence by modulating FimS-AlgR activity. PLoS Pathog. 2018;14:e1007074.  doi: 10.1371/journal.ppat.1007074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1007074</ArticleId>
            <ArticleId IdType="pmc">PMC5979040</ArticleId>
            <ArticleId IdType="pubmed">29775484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee K.K., Sheth H.B., Wong W.Y., Sherburne R., Paranchych W., Hodges R.S., Lingwood C.A., Krivan H., Irvin R.T. The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip-associated event involving the C-terminal region of the structural pilin subunit. Mol. Microbiol. 1994;11:705–713. doi: 10.1111/j.1365-2958.1994.tb00348.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.1994.tb00348.x</ArticleId>
            <ArticleId IdType="pubmed">7910938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Craig L., Pique M.E., Tainer J.A. Type IV pilus structure and bacterial pathogenicity. Nat. Rev. Microbiol. 2004;2:363–378. doi: 10.1038/nrmicro885.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro885</ArticleId>
            <ArticleId IdType="pubmed">15100690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schroeder T.H., Zaidi T., Pier G.B. Lack of adherence of clinical isolates of Pseudomonas aeruginosa to asialo-GM(1) on epithelial cells. Infect. Immun. 2001;69:719–729. doi: 10.1128/IAI.69.2.719-729.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.69.2.719-729.2001</ArticleId>
            <ArticleId IdType="pmc">PMC97944</ArticleId>
            <ArticleId IdType="pubmed">11159960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tolker-Nielsen T. Pseudomonas aeruginosa biofilm infections: From molecular biofilm biology to new treatment possibilities. APMIS. 2014;138:1–51. doi: 10.1111/apm.12335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apm.12335</ArticleId>
            <ArticleId IdType="pubmed">25399808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Schaik E.J., Giltner C.L., Audette G.F., Keizer D.W., Bautista D.L., Slupsky C.M., Sykes B.D., Irvin R.T. DNA binding: A novel function of Pseudomonas aeruginosa type IV pili. J. Bacteriol. 2005;187:1455–1464. doi: 10.1128/JB.187.4.1455-1464.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.187.4.1455-1464.2005</ArticleId>
            <ArticleId IdType="pmc">PMC545619</ArticleId>
            <ArticleId IdType="pubmed">15687210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan R.M., Kuang Z., Hao Y., Lau G.W. Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A. J. Innate Immun. 2014;6:227–239. doi: 10.1159/000354304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000354304</ArticleId>
            <ArticleId IdType="pmc">PMC3944384</ArticleId>
            <ArticleId IdType="pubmed">24080545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arlehamn C.S., Evans T.J. Pseudomonas aeruginosa pilin activates the inflammasome. Cell Microbiol. 2011;13:388–401. doi: 10.1111/j.1462-5822.2010.01541.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-5822.2010.01541.x</ArticleId>
            <ArticleId IdType="pmc">PMC3429865</ArticleId>
            <ArticleId IdType="pubmed">20955240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bleves S., Viarre V., Salacha R., Michel G.P., Filloux A., Voulhoux R. Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons. Int. J. Med. Microbiol. 2010;300:534–543. doi: 10.1016/j.ijmm.2010.08.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2010.08.005</ArticleId>
            <ArticleId IdType="pubmed">20947426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pena R.T., Blasco L., Ambroa A., González-Pedrajo B., Fernández-García L., López M., Bleriot I., Bou G., García-Contreras R., Wood T.K., et al.  Relationship Between Quorum Sensing and Secretion Systems. Front. Microbiol. 2019;10:1100. doi: 10.3389/fmicb.2019.01100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2019.01100</ArticleId>
            <ArticleId IdType="pmc">PMC6567927</ArticleId>
            <ArticleId IdType="pubmed">31231316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao K., Li W., Li J., Ma T., Wang K., Yuan Y., Li J.S., Xie R., Huang T., Zhang Y., et al.  TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection. Nat. Microbiol. 2019;4:459–469. doi: 10.1038/s41564-018-0322-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41564-018-0322-4</ArticleId>
            <ArticleId IdType="pubmed">30617346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anantharajah A., Mingeot-Leclercq M.P., Van Bambeke F. Targeting the Type Three Secretion System in Pseudomonas aeruginosa. Trends Pharmacol. Sci. 2016;37:734–749. doi: 10.1016/j.tips.2016.05.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tips.2016.05.011</ArticleId>
            <ArticleId IdType="pubmed">27344210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sana T.G., Berni B., Bleves S. The T6SSs of Pseudomonas aeruginosa Strain PAO1 and Their Effectors: Beyond Bacterial-Cell Targeting. Front. Cell Infect. Microbiol. 2016;6:61. doi: 10.3389/fcimb.2016.00061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2016.00061</ArticleId>
            <ArticleId IdType="pmc">PMC4899435</ArticleId>
            <ArticleId IdType="pubmed">27376031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goure J., Pastor A., Faudry E., Chabert J., Dessen A., Attree I. The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes. Infect. Immun. 2004;72:4741–4750. doi: 10.1128/IAI.72.8.4741-4750.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.72.8.4741-4750.2004</ArticleId>
            <ArticleId IdType="pmc">PMC470589</ArticleId>
            <ArticleId IdType="pubmed">15271936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams McMackin E.A., Djapgne L., Corley J.M., Yahr T.L. Fitting Pieces into the Puzzle of Pseudomonas aeruginosa Type III Secretion System Gene Expression. J. Bacteriol. 2019;201 doi: 10.1128/JB.00209-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00209-19</ArticleId>
            <ArticleId IdType="pmc">PMC6560140</ArticleId>
            <ArticleId IdType="pubmed">31010903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burstein D., Satanower S., Simovitch M., Belnik Y., Zehavi M., Yerushalmi G., Ben-Aroya S., Pupko T., Banin E. Novel type III effectors in Pseudomonas aeruginosa. mBio. 2015;6:e00161. doi: 10.1128/mBio.00161-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00161-15</ArticleId>
            <ArticleId IdType="pmc">PMC4453518</ArticleId>
            <ArticleId IdType="pubmed">25784698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ince D., Sutterwala F.S., Yahr T.L. Secretion of Flagellar Proteins by the Pseudomonas aeruginosa Type III Secretion-Injectisome System. J. Bacteriol. 2015;197:2003–2011. doi: 10.1128/JB.00030-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00030-15</ArticleId>
            <ArticleId IdType="pmc">PMC4438214</ArticleId>
            <ArticleId IdType="pubmed">25845843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neeld D., Jin Y., Bichsel C., Jia J., Guo J., Bai F., Wu W., Ha U.H., Terada N., Jin S. Pseudomonas aeruginosa injects NDK into host cells through a type III secretion system. Microbiology. 2014;160:1417–1426. doi: 10.1099/mic.0.078139-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.078139-0</ArticleId>
            <ArticleId IdType="pmc">PMC4076871</ArticleId>
            <ArticleId IdType="pubmed">24699069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Javanmardi F., Emami A., Pirbonyeh N., Keshavarzi A., Rajaee M. A systematic review and meta-analysis on Exo-toxins prevalence in hospital acquired Pseudomonas aeruginosa isolates. Infect. Genet. Evol. 2019;75:104037. doi: 10.1016/j.meegid.2019.104037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.meegid.2019.104037</ArticleId>
            <ArticleId IdType="pubmed">31518698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaver C.M., Hauser A.R. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect. Immun. 2004;72:6969–6977. doi: 10.1128/IAI.72.12.6969-6977.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.72.12.6969-6977.2004</ArticleId>
            <ArticleId IdType="pmc">PMC529154</ArticleId>
            <ArticleId IdType="pubmed">15557619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howell H.A., Logan L.K., Hauser A.R. Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia. mBio. 2013;4:e00032-13. doi: 10.1128/mBio.00032-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00032-13</ArticleId>
            <ArticleId IdType="pmc">PMC3604777</ArticleId>
            <ArticleId IdType="pubmed">23481600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peña C., Cabot G., Gómez-Zorrilla S., Zamorano L., Ocampo-Sosa A., Murillas J., Almirante B., Pomar V., Aguilar M., Granados A., et al.  Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections. Clin. Infect. Dis. 2015;60:539–548. doi: 10.1093/cid/ciu866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciu866</ArticleId>
            <ArticleId IdType="pubmed">25378459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hauser A.R. The type III secretion system of Pseudomonas aeruginosa: Infection by injection. Nat. Rev. Microbiol. 2009;7:654–665. doi: 10.1038/nrmicro2199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro2199</ArticleId>
            <ArticleId IdType="pmc">PMC2766515</ArticleId>
            <ArticleId IdType="pubmed">19680249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Lima C.D., Calegari-Silva T.C., Pereira R.M., Santos S.A., Lopes U.G., Plotkowski M.C., Saliba A.M. ExoU activates NF-κB and increases IL-8/KC secretion during Pseudomonas aeruginosa infection. PLoS ONE. 2012;7:e41772.  doi: 10.1371/journal.pone.0041772.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0041772</ArticleId>
            <ArticleId IdType="pmc">PMC3406076</ArticleId>
            <ArticleId IdType="pubmed">22848596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pazos M.A., Lanter B.B., Yonker L.M., Eaton A.D., Pirzai W., Gronert K., Bonventre J.V., Hurley B.P. Pseudomonas aeruginosa ExoU augments neutrophil transepithelial migration. PLoS Pathog. 2017;13:e1006548.  doi: 10.1371/journal.ppat.1006548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1006548</ArticleId>
            <ArticleId IdType="pmc">PMC5557605</ArticleId>
            <ArticleId IdType="pubmed">28771621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wagener B.M., Anjum N., Christiaans S.C., Banks M.E., Parker J.C., Threet A.T., Walker R.R., Isbell K.D., Moser S.A., Stevens T., et al.  Exoenzyme Y Contributes to End-Organ Dysfunction Caused by Pseudomonas aeruginosa Pneumonia in Critically Ill Patients: An Exploratory Study. Toxins. 2020;12:369.  doi: 10.3390/toxins12060369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins12060369</ArticleId>
            <ArticleId IdType="pmc">PMC7354586</ArticleId>
            <ArticleId IdType="pubmed">32512716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beckert U., Wolter S., Hartwig C., Bähre H., Kaever V., Ladant D., Frank D.W., Seifert R. ExoY from Pseudomonas aeruginosa is a nucleotidyl cyclase with preference for cGMP and cUMP formation. Biochem. Biophys. Res. Commun. 2014;450:870–874. doi: 10.1016/j.bbrc.2014.06.088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2014.06.088</ArticleId>
            <ArticleId IdType="pmc">PMC4764875</ArticleId>
            <ArticleId IdType="pubmed">24971548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stevens T.C., Ochoa C.D., Morrow K.A., Robson M.J., Prasain N., Zhou C., Alvarez D.F., Frank D.W., Balczon R., Stevens T. The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2014;306:L915–L924. doi: 10.1152/ajplung.00135.2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajplung.00135.2013</ArticleId>
            <ArticleId IdType="pmc">PMC4025060</ArticleId>
            <ArticleId IdType="pubmed">24705722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mancl J.M., Suarez C., Liang W.G., Kovar D.R., Tang W.J. Pseudomonas aeruginosa exoenzyme Y directly bundles actin filaments. J. Biol. Chem. 2020;295:3506–3517. doi: 10.1074/jbc.RA119.012320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.RA119.012320</ArticleId>
            <ArticleId IdType="pmc">PMC7076225</ArticleId>
            <ArticleId IdType="pubmed">32019868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He C., Zhou Y., Liu F., Liu H., Tan H., Jin S., Wu W., Ge B. Bacterial Nucleotidyl Cyclase Inhibits the Host Innate Immune Response by Suppressing TAK1 Activation. Infect. Immun. 2017;85 doi: 10.1128/IAI.00239-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00239-17</ArticleId>
            <ArticleId IdType="pmc">PMC5563585</ArticleId>
            <ArticleId IdType="pubmed">28652310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armentrout E.I., Kundracik E.C., Rietsch A. Cell-type-specific hypertranslocation of effectors by the Pseudomonas aeruginosa type III secretion system. Mol. Microbiol. 2020 doi: 10.1111/mmi.14617.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/mmi.14617</ArticleId>
            <ArticleId IdType="pmc">PMC7897236</ArticleId>
            <ArticleId IdType="pubmed">33012037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun J., Barbieri J.T. Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins. J. Biol. Chem. 2003;278:32794–32800. doi: 10.1074/jbc.M304290200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M304290200</ArticleId>
            <ArticleId IdType="pubmed">12807879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vourc’h M., Roquilly A., Broquet A., David G., Hulin P., Jacqueline C., Caillon J., Retiere C., Asehnoune K. Exoenzyme T Plays a Pivotal Role in the IFN-γ Production after Pseudomonas Challenge in IL-12 Primed Natural Killer Cells. Front. Immunol. 2017;8:1283. doi: 10.3389/fimmu.2017.01283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.01283</ArticleId>
            <ArticleId IdType="pmc">PMC5641345</ArticleId>
            <ArticleId IdType="pubmed">29067027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarges E.D.S.N., Rodrigues Y.C., Furlaneto I.P., de Melo M.V.H., Brabo G.L.D.C., Lopes K.C.M., Quaresma A.J.P.G., Lima L.N.G.C., Lima K.V.B. Type III Secretion System Virulotypes and Their Association with Clinical Features of Cystic Fibrosis Patients. Infect. Drug Resist. 2020;13:3771–3781. doi: 10.2147/IDR.S273759.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IDR.S273759</ArticleId>
            <ArticleId IdType="pmc">PMC7588269</ArticleId>
            <ArticleId IdType="pubmed">33116695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rangel S.M., Diaz M.H., Knoten C.A., Zhang A., Hauser A.R. Correction: The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia. PLoS Pathog. 2015;11:e1005163.  doi: 10.1371/journal.ppat.1005163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1005163</ArticleId>
            <ArticleId IdType="pmc">PMC4574960</ArticleId>
            <ArticleId IdType="pubmed">26378929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rangel S.M., Logan L.K., Hauser A.R. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia. mBio. 2014;5:e01080-14. doi: 10.1128/mBio.01080-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.01080-14</ArticleId>
            <ArticleId IdType="pmc">PMC4056551</ArticleId>
            <ArticleId IdType="pubmed">24917597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vareechon C., Zmina S.E., Karmakar M., Pearlman E., Rietsch A. Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils. Cell Host Microbe. 2017;21:611–618. doi: 10.1016/j.chom.2017.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chom.2017.04.001</ArticleId>
            <ArticleId IdType="pmc">PMC5478421</ArticleId>
            <ArticleId IdType="pubmed">28494242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Epelman S., Stack D., Bell C., Wong E., Neely G.G., Krutzik S., Miyake K., Kubes P., Zbytnuik L.D., Ma L.L., et al.  Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs. J. Immunol. 2004;173:2031–2040. doi: 10.4049/jimmunol.173.3.2031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.173.3.2031</ArticleId>
            <ArticleId IdType="pubmed">15265938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galle M., Jin S., Bogaert P., Haegman M., Vandenabeele P., Beyaert R. The Pseudomonas aeruginosa type III secretion system has an exotoxin S/T/Y independent pathogenic role during acute lung infection. PLoS ONE. 2012;7:e41547.  doi: 10.1371/journal.pone.0041547.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0041547</ArticleId>
            <ArticleId IdType="pmc">PMC3402384</ArticleId>
            <ArticleId IdType="pubmed">22844497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faure E., Mear J.B., Faure K., Normand S., Couturier-Maillard A., Grandjean T., Balloy V., Ryffel B., Dessein R., Chignard M., et al.  Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome. Am. J. Respir. Crit. Care Med. 2014;189:799–811. doi: 10.1164/rccm.201307-1358OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201307-1358OC</ArticleId>
            <ArticleId IdType="pubmed">24555512</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michalska M., Wolf P. Pseudomonas Exotoxin A: Optimized by evolution for effective killing. Front. Microbiol. 2015;6:963. doi: 10.3389/fmicb.2015.00963.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2015.00963</ArticleId>
            <ArticleId IdType="pmc">PMC4584936</ArticleId>
            <ArticleId IdType="pubmed">26441897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf P., Elsässer-Beile U. Pseudomonas exotoxin A: From virulence factor to anti-cancer agent. Int. J. Med. Microbiol. 2009;299:161–176. doi: 10.1016/j.ijmm.2008.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2008.08.003</ArticleId>
            <ArticleId IdType="pubmed">18948059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du X., Youle R.J., FitzGerald D.J., Pastan I. Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1. Mol. Cell Biol. 2010;30:3444–3452. doi: 10.1128/MCB.00813-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00813-09</ArticleId>
            <ArticleId IdType="pmc">PMC2897547</ArticleId>
            <ArticleId IdType="pubmed">20457813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schultz M.J., Rijneveld A.W., Florquin S., Speelman P., VAN Deventer S.J.H., VAN DER Poll T. Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice. J. Med. Microbiol. 2001;50:822–827. doi: 10.1099/0022-1317-50-9-822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/0022-1317-50-9-822</ArticleId>
            <ArticleId IdType="pubmed">11549184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schultz M.J., Speelman P., Zaat S.A., Hack C.E., van Deventer S.J., van der Poll T. The effect of Pseudomonas exotoxin A on cytokine production in whole blood exposed to Pseudomonas aeruginosa. FEMS Immunol. Med. Microbiol. 2000;29:227–232. doi: 10.1111/j.1574-695X.2000.tb01527.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-695X.2000.tb01527.x</ArticleId>
            <ArticleId IdType="pubmed">11064270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galdino A.C.M., Branquinha M.H., Santos A.L.S., Viganor L.  Pathophysiological Aspects of Proteases. Springer Nature; Singapore: 2017. Pseudomonas aeruginosa and its arsenal of proteases: Weapons to battle the host; pp. 381–397.</Citation>
        </Reference>
        <Reference>
          <Citation>Li X.H., Lee J.H. Quorum sensing-dependent post-secretional activation of extracellular proteases in Pseudomonas aeruginosa. J. Biol. Chem. 2019;294:19635–19644. doi: 10.1074/jbc.RA119.011047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.RA119.011047</ArticleId>
            <ArticleId IdType="pmc">PMC6926461</ArticleId>
            <ArticleId IdType="pubmed">31727738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gellatly S.L., Hancock R.E. Pseudomonas aeruginosa: New insights into pathogenesis and host defenses. Pathog. Dis. 2013;67:159–173. doi: 10.1111/2049-632X.12033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/2049-632X.12033</ArticleId>
            <ArticleId IdType="pubmed">23620179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nomura K., Obata K., Keira T., Miyata R., Hirakawa S., Takano K., Kohno T., Sawada N., Himi T., Kojima T. Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells. Respir. Res. 2014;15:21. doi: 10.1186/1465-9921-15-21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1465-9921-15-21</ArticleId>
            <ArticleId IdType="pmc">PMC3936699</ArticleId>
            <ArticleId IdType="pubmed">24548792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mariencheck W.I., Alcorn J.F., Palmer S.M., Wright J.R. Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. Am. J. Respir. Cell Mol. Biol. 2003;28:528–537. doi: 10.1165/rcmb.2002-0141OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2002-0141OC</ArticleId>
            <ArticleId IdType="pubmed">12654643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuang Z., Hao Y., Walling B.E., Jeffries J.L., Ohman D.E., Lau G.W. Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A. PLoS ONE. 2011;6:e27091.  doi: 10.1371/journal.pone.0027091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0027091</ArticleId>
            <ArticleId IdType="pmc">PMC3206073</ArticleId>
            <ArticleId IdType="pubmed">22069491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saint-Criq V., Villeret B., Bastaert F., Kheir S., Hatton A., Cazes A., Xing Z., Sermet-Gaudelus I., Garcia-Verdugo I., Edelman A., et al.  LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway. Thorax. 2018;73:49–61. doi: 10.1136/thoraxjnl-2017-210298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thoraxjnl-2017-210298</ArticleId>
            <ArticleId IdType="pmc">PMC5738602</ArticleId>
            <ArticleId IdType="pubmed">28790180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang J., Lee K.M., Park S., Cho Y., Lee E., Park J.H., Shin O.S., Son J., Yoon S.S., Yu J.W. Bacterial secretant from Pseudomonas aeruginosa Dampens inflammasome activation in a Quorum sensing-Dependent Manner. Front. Immunol. 2017;8:333. doi: 10.3389/fimmu.2017.00333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.00333</ArticleId>
            <ArticleId IdType="pmc">PMC5366846</ArticleId>
            <ArticleId IdType="pubmed">28396663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casilag F., Lorenz A., Krueger J., Klawonn F., Weiss S., Häussler S. The LasB Elastase of Pseudomonas aeruginosa Acts in Concert with Alkaline Protease AprA To Prevent Flagellin-Mediated Immune Recognition. Infect. Immun. 2016;84:162–171. doi: 10.1128/IAI.00939-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00939-15</ArticleId>
            <ArticleId IdType="pmc">PMC4693985</ArticleId>
            <ArticleId IdType="pubmed">26502908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bastaert F., Kheir S., Saint-Criq V., Villeret B., Dang P.M., El-Benna J., Sirard J.C., Voulhoux R., Sallenave J.M. LasB Subverts Alveolar Macrophage Activity by Interfering with Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation. Front. Immunol. 2018;9:1675. doi: 10.3389/fimmu.2018.01675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2018.01675</ArticleId>
            <ArticleId IdType="pmc">PMC6064941</ArticleId>
            <ArticleId IdType="pubmed">30083156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu H., He X., Xie W., Xiong J., Sheng H., Guo S., Huang C., Zhang D., Zhang K. Elastase LasB of Pseudomonas aeruginosa promotes biofilm formation partly through rhamnolipid-mediated regulation. Can. J. Microbiol. 2014;60:227–235. doi: 10.1139/cjm-2013-0667.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1139/cjm-2013-0667</ArticleId>
            <ArticleId IdType="pubmed">24693981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krishnan G., Sethumadhavan A., Muthusamy S., Mani M. Antibiotic resistant clinical isolates of Pseudomonas aeruginosa harbor LasA gene. Internet J. Microbiol. 2019;16 doi: 10.5580/IJMB.53869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5580/IJMB.53869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laarman A.J., Bardoel B.W., Ruyken M., Fernie J., Milder F.J., van Strijp J.A., Rooijakkers S.H. Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways. J. Immunol. 2012;188:386–393. doi: 10.4049/jimmunol.1102162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1102162</ArticleId>
            <ArticleId IdType="pubmed">22131330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bardoel B.W., van der Ent S., Pel M.J., Tommassen J., Pieterse C.M., van Kessel K.P., van Strijp J.A. Pseudomonas evades immune recognition of flagellin in both mammals and plants. PLoS Pathog. 2011;7:e1002206.  doi: 10.1371/journal.ppat.1002206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1002206</ArticleId>
            <ArticleId IdType="pmc">PMC3161968</ArticleId>
            <ArticleId IdType="pubmed">21901099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butterworth M.B., Zhang L., Heidrich E.M., Myerburg M.M., Thibodeau P.H. Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa. J. Biol. Chem. 2012;287:32556–32565. doi: 10.1074/jbc.M112.369520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.369520</ArticleId>
            <ArticleId IdType="pmc">PMC3463336</ArticleId>
            <ArticleId IdType="pubmed">22859302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iiyama K., Takahashi E., Lee J.M., Mon H., Morishita M., Kusakabe T., Yasunaga-Aoki C. Alkaline protease contributes to pyocyanin production in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 2017;364 doi: 10.1093/femsle/fnx051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/femsle/fnx051</ArticleId>
            <ArticleId IdType="pubmed">28333255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conibear T.C.R., Willcox M.D.P., Flanagan J.L., Zhu H. Characterization of protease IV expression in Pseudomonas aeruginosa clinical isolates. J. Med. Microbiol. 2012;61:180–190. doi: 10.1099/jmm.0.034561-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.034561-0</ArticleId>
            <ArticleId IdType="pubmed">21921113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malloy J.L., Veldhuizen R.A., Thibodeaux B.A., O’Callaghan R.J., Wright J.R. Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am. J. Physiol. Lung Cell Mol. Physiol. 2005;288:L409–L418. doi: 10.1152/ajplung.00322.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajplung.00322.2004</ArticleId>
            <ArticleId IdType="pubmed">15516485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith L., Rose B., Tingpej P., Zhu H., Conibear T., Manos J., Bye P., Elkins M., Willcox M., Bell S., et al.  Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis. J. Med. Microbiol. 2006;55:1641–1644. doi: 10.1099/jmm.0.46845-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.46845-0</ArticleId>
            <ArticleId IdType="pubmed">17108265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guillon A., Brea D., Morello E., Tang A., Jouan Y., Ramphal R., Korkmaz B., Perez-Cruz M., Trottein F., O’Callaghan R.J., et al.  Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense. Virulence. 2017;8:810–820. doi: 10.1080/21505594.2016.1253658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21505594.2016.1253658</ArticleId>
            <ArticleId IdType="pmc">PMC5626239</ArticleId>
            <ArticleId IdType="pubmed">27792459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bradshaw J.L., Caballero A.R., Bierdeman M.A., Adams K.V., Pipkins H.R., Tang A., O’Callaghan R.J., McDaniel L.S. Pseudomonas aeruginosa Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease. mSphere. 2018;3 doi: 10.1128/mSphere.00212-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mSphere.00212-18</ArticleId>
            <ArticleId IdType="pmc">PMC5932373</ArticleId>
            <ArticleId IdType="pubmed">29720526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park S.J., Kim S.K., So Y.I., Park H.Y., Li X.H., Yeom D.H., Lee M.N., Lee B.L., Lee J.H. Protease IV, a quorum sensing-dependent protease of Pseudomonas aeruginosa modulates insect innate immunity. Mol. Microbiol. 2014;94:1298–1314. doi: 10.1111/mmi.12830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/mmi.12830</ArticleId>
            <ArticleId IdType="pubmed">25315216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verma N., Dollinger P., Kovacic F., Jaeger K.E., Gohlke H. The Membrane-Integrated Steric Chaperone Lif Facilitates Active Site Opening of Pseudomonas aeruginosa Lipase A. J. Comput. Chem. 2020;41:500–512. doi: 10.1002/jcc.26085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcc.26085</ArticleId>
            <ArticleId IdType="pubmed">31618459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bofill C., Prim N., Mormeneo M., Manresa A., Pastor F.I., Diaz P. Differential behaviour of Pseudomonas sp. 42A2 LipC, a lipase showing greater versatility than its counterpart LipA. Biochimie. 2010;92:307–316. doi: 10.1016/j.biochi.2009.11.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biochi.2009.11.005</ArticleId>
            <ArticleId IdType="pubmed">19944735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berdiev N.S., Ziyavitdinov J.F., Asrorov A.M., Olimjonov S.S., Salikhov S.I. Characterization of a novel lipase from Pseudomonas aeruginosa. Nova Biotechnol. Chim. 2019;18:44–51. doi: 10.2478/nbec-2019-0006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2478/nbec-2019-0006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kipnis E., Sawa T., Wiener-Kronish J. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med. Mal. Infect. 2006;36:78–91. doi: 10.1016/j.medmal.2005.10.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.medmal.2005.10.007</ArticleId>
            <ArticleId IdType="pubmed">16427231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wargo M.J., Gross M.J., Rajamani S., Allard J.L., Lundblad L.K., Allen G.B., Vasil M.L., Leclair L.W., Hogan D.A. Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. Am. J. Respir. Crit. Care Med. 2011;184:345–354. doi: 10.1164/rccm.201103-0374OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201103-0374OC</ArticleId>
            <ArticleId IdType="pmc">PMC3175536</ArticleId>
            <ArticleId IdType="pubmed">21562128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bezzerri V., d’Adamo P., Rimessi A., Lanzara C., Crovella S., Nicolis E., Tamanini A., Athanasakis E., Tebon M., Bisoffi G., et al.  Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells. J. Immunol. 2011;186:4946–4958. doi: 10.4049/jimmunol.1003535.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1003535</ArticleId>
            <ArticleId IdType="pmc">PMC4166552</ArticleId>
            <ArticleId IdType="pubmed">21411730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall S., McDermott C., Anoopkumar-Dukie S., McFarland A.J., Forbes A., Perkins A.V., Davey A.K., Chess-Williams R., Kiefel M.J., Arora D., et al.  Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosa. Toxins. 2016;8:236.  doi: 10.3390/toxins8080236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/toxins8080236</ArticleId>
            <ArticleId IdType="pmc">PMC4999852</ArticleId>
            <ArticleId IdType="pubmed">27517959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeng B., Wang C., Zhang P., Guo Z., Chen L., Duan K. Heat shock protein DnaJ in Pseudomonas aeruginosa affects biofilm formation via pyocyanin production. Microorganisms. 2020;8:395.  doi: 10.3390/microorganisms8030395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/microorganisms8030395</ArticleId>
            <ArticleId IdType="pmc">PMC7143733</ArticleId>
            <ArticleId IdType="pubmed">32178243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Managò A., Becker K.A., Carpinteiro A., Wilker B., Soddemann M., Seitz A.P., Edwards M.J., Grassmé H., Szabò I., Gulbins E. Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase. Antioxid. Redox Signal. 2015;22:1097–1110. doi: 10.1089/ars.2014.5979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/ars.2014.5979</ArticleId>
            <ArticleId IdType="pmc">PMC4403017</ArticleId>
            <ArticleId IdType="pubmed">25686490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alfiniyah C., Bees M.A., Wood A.J. Quorum machinery: Effect of the las system in rhl regulation of P. aeruginosa. AIP Conf. Proc. 2019;2192:060001. doi: 10.1063/1.5139147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1063/1.5139147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halldorsson S., Gudjonsson T., Gottfredsson M., Singh P.K., Gudmundsson G.H., Baldursson O. Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. Am. J. Respir. Cell Mol. Biol. 2010;42:62–68. doi: 10.1165/rcmb.2008-0357OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2008-0357OC</ArticleId>
            <ArticleId IdType="pubmed">19372247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zulianello L., Canard C., Köhler T., Caille D., Lacroix J.S., Meda P. Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect. Immun. 2006;74:3134–3137. doi: 10.1128/IAI.01772-05.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.01772-05</ArticleId>
            <ArticleId IdType="pmc">PMC1479292</ArticleId>
            <ArticleId IdType="pubmed">16714541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Köhler T., Guanella R., Carlet J., van Delden C. Quorum sensing-dependent virulence during Pseudomonas aeruginosa colonisation and pneumonia in mechanically ventilated patients. Thorax. 2010;65:703–710. doi: 10.1136/thx.2009.133082.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thx.2009.133082</ArticleId>
            <ArticleId IdType="pubmed">20685744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raya A., Sodagari M., Pinzon N.M., He X., Zhang Newby B.M., Ju L.K. Effects of rhamnolipids and shear on initial attachment of Pseudomonas aeruginosa PAO1 in glass flow chambers. Environ. Sci. Pollut Res. Int. 2010;17:1529–1538. doi: 10.1007/s11356-010-0339-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11356-010-0339-6</ArticleId>
            <ArticleId IdType="pubmed">20509051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nickzad A., Déziel E. The involvement of rhamnolipids in microbial cell adhesion and biofilm development—An approach for control? Lett. Appl. Microbiol. 2014;58:447–453. doi: 10.1111/lam.12211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/lam.12211</ArticleId>
            <ArticleId IdType="pubmed">24372465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davey M.E., Caiazza N.C., O’Toole G.A. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J. Bacteriol. 2003;185:1027–1036. doi: 10.1128/JB.185.3.1027-1036.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.185.3.1027-1036.2003</ArticleId>
            <ArticleId IdType="pmc">PMC142794</ArticleId>
            <ArticleId IdType="pubmed">12533479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray T.S., Kazmierczak B.I. Pseudomonas aeruginosa exhibits sliding motility in the absence of type IV pili and flagella. J. Bacteriol. 2008;190:2700–2708. doi: 10.1128/JB.01620-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01620-07</ArticleId>
            <ArticleId IdType="pmc">PMC2293233</ArticleId>
            <ArticleId IdType="pubmed">18065549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremblay J., Richardson A.P., Lépine F., Déziel E. Self-produced extracellular stimuli modulate the Pseudomonas aeruginosa swarming motility behaviour. Environ. Microbiol. 2007;9:2622–2630. doi: 10.1111/j.1462-2920.2007.01396.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-2920.2007.01396.x</ArticleId>
            <ArticleId IdType="pubmed">17803784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S., Yu S., Zhang Z., Wei Q., Yan L., Ai G., Liu H., Ma L.Z. Coordination of swarming motility, biosurfactant synthesis, and biofilm matrix exopolysaccharide production in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 2014;80:6724–6732. doi: 10.1128/AEM.01237-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.01237-14</ArticleId>
            <ArticleId IdType="pmc">PMC4249032</ArticleId>
            <ArticleId IdType="pubmed">25172852</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glick R., Gilmour C., Tremblay J., Satanower S., Avidan O., Déziel E., Greenberg E.P., Poole K., Banin E. Increase in rhamnolipid synthesis under iron-limiting conditions influences surface motility and biofilm formation in Pseudomonas aeruginosa. J. Bacteriol. 2010;192:2973–2980. doi: 10.1128/JB.01601-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01601-09</ArticleId>
            <ArticleId IdType="pmc">PMC2901684</ArticleId>
            <ArticleId IdType="pubmed">20154129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jensen P.Ø., Bjarnsholt T., Phipps R., Rasmussen T.B., Calum H., Christoffersen L., Moser C., Williams P., Pressler T., Givskov M., et al.  Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology. 2007;153:1329–1338. doi: 10.1099/mic.0.2006/003863-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.2006/003863-0</ArticleId>
            <ArticleId IdType="pubmed">17464047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alhede M., Bjarnsholt T., Jensen P., Phipps R.K., Moser C., Christophersen L., Christensen L.D., van Gennip M., Parsek M., Høiby N., et al.  Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology. 2009;155:3500–3508. doi: 10.1099/mic.0.031443-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.031443-0</ArticleId>
            <ArticleId IdType="pubmed">19643762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dössel J., Meyer-Hoffert U., Schröder J.M., Gerstel U. Pseudomonas aeruginosa-derived rhamnolipids subvert the host innate immune response through manipulation of the human beta-defensin-2 expression. Cell Microbiol. 2012;14:1364–1375. doi: 10.1111/j.1462-5822.2012.01801.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-5822.2012.01801.x</ArticleId>
            <ArticleId IdType="pubmed">22500651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malhotra S., Hayes D., Wozniak D.J. Cystic Fibrosis and Pseudomonas aeruginosa: The Host-Microbe Interface. Clin. Microbiol. Rev. 2019;32:e00138-18. doi: 10.1128/CMR.00138-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00138-18</ArticleId>
            <ArticleId IdType="pmc">PMC6589863</ArticleId>
            <ArticleId IdType="pubmed">31142499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S.H., Lee B.Y., Lau G.W., Cho Y.H. IscR modulates catalase A (KatA) activity, peroxide resistance and full virulence of Pseudomonas aeruginosa PA14. J. Microbiol. Biotechnol. 2009;19:1520–1526. doi: 10.4014/jmb.0906.06028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4014/jmb.0906.06028</ArticleId>
            <ArticleId IdType="pubmed">20075613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heo Y.J., Chung I.Y., Cho W.J., Lee B.Y., Kim J.H., Choi K.H., Lee J.W., Hassett D.J., Cho Y.H. The major catalase gene (katA) of Pseudomonas aeruginosa PA14 is under both positive and negative control of the global transactivator OxyR in response to hydrogen peroxide. J. Bacteriol. 2010;192:381–390. doi: 10.1128/JB.00980-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00980-09</ArticleId>
            <ArticleId IdType="pmc">PMC2805318</ArticleId>
            <ArticleId IdType="pubmed">19933365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khakimova M., Ahlgren H.G., Harrison J.J., English A.M., Nguyen D. The stringent response controls catalases in Pseudomonas aeruginosa and is required for hydrogen peroxide and antibiotic tolerance. J. Bacteriol. 2013;195:2011–2020. doi: 10.1128/JB.02061-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.02061-12</ArticleId>
            <ArticleId IdType="pmc">PMC3624573</ArticleId>
            <ArticleId IdType="pubmed">23457248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin D.H., Choi Y.S., Cho Y.H. Unusual properties of catalase A (KatA) of Pseudomonas aeruginosa PA14 are associated with its biofilm peroxide resistance. J. Bacteriol. 2008;190:2663–2670. doi: 10.1128/JB.01580-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01580-07</ArticleId>
            <ArticleId IdType="pmc">PMC2293238</ArticleId>
            <ArticleId IdType="pubmed">18165301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J.S., Heo Y.J., Lee J.K., Cho Y.H. KatA, the major catalase, is critical for osmoprotection and virulence in Pseudomonas aeruginosa PA14. Infect. Immun. 2005;73:4399–4403. doi: 10.1128/IAI.73.7.4399-4403.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.73.7.4399-4403.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1168586</ArticleId>
            <ArticleId IdType="pubmed">15972537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su S., Panmanee W., Wilson J.J., Mahtani H.K., Li Q., Vanderwielen B.D., Makris T.M., Rogers M., McDaniel C., Lipscomb J.D., et al.  Catalase (KatA) plays a role in protection against anaerobic nitric oxide in Pseudomonas aeruginosa. PLoS ONE. 2014;9:e91813.  doi: 10.1371/journal.pone.0091813.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0091813</ArticleId>
            <ArticleId IdType="pmc">PMC3963858</ArticleId>
            <ArticleId IdType="pubmed">24663218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dauner M., Skerra A. Scavenging Bacterial Siderophores with Engineered Lipocalin Proteins as an Alternative Antimicrobial Strategy. ChemBioChem. 2020;21:601–606. doi: 10.1002/cbic.201900564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cbic.201900564</ArticleId>
            <ArticleId IdType="pmc">PMC7079049</ArticleId>
            <ArticleId IdType="pubmed">31613035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cornelis P., Dingemans J. Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections. Front. Cell Infect. Microbiol. 2013;3:75. doi: 10.3389/fcimb.2013.00075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2013.00075</ArticleId>
            <ArticleId IdType="pmc">PMC3827675</ArticleId>
            <ArticleId IdType="pubmed">24294593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonneau A., Roche B., Schalk I.J. Iron acquisition in Pseudomonas aeruginosa by the siderophore pyoverdine: An intricate interacting network including periplasmic and membrane proteins. Sci. Rep. 2020;10:120. doi: 10.1038/s41598-019-56913-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-56913-x</ArticleId>
            <ArticleId IdType="pmc">PMC6954188</ArticleId>
            <ArticleId IdType="pubmed">31924850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang D., Kirienko N.V. Interdependence between iron acquisition and biofilm formation in Pseudomonas aeruginosa. J. Microbiol. 2018;56:449–457. doi: 10.1007/s12275-018-8114-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12275-018-8114-3</ArticleId>
            <ArticleId IdType="pmc">PMC6221862</ArticleId>
            <ArticleId IdType="pubmed">29948830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cornelis P., Matthijs S., Van Oeffelen L. Iron uptake regulation in Pseudomonas aeruginosa. Biometals. 2009;22:15–22. doi: 10.1007/s10534-008-9193-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10534-008-9193-0</ArticleId>
            <ArticleId IdType="pubmed">19130263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J., Zhang L. The hierarchy quorum sensing network in Pseudomonas aeruginosa. Protein Cell. 2015;6:26–41. doi: 10.1007/s13238-014-0100-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13238-014-0100-x</ArticleId>
            <ArticleId IdType="pmc">PMC4286720</ArticleId>
            <ArticleId IdType="pubmed">25249263</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wade D.S., Calfee M.W., Rocha E.R., Ling E.A., Engstrom E., Coleman J.P., Pesci E.C. Regulation of Pseudomonas quinolone signal synthesis in Pseudomonas aeruginosa. J. Bacteriol. 2005;187:4372–4380. doi: 10.1128/JB.187.13.4372-4380.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.187.13.4372-4380.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1151766</ArticleId>
            <ArticleId IdType="pubmed">15968046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J., Wu J., Deng Y., Wang J., Wang C., Chang C., Dong Y., Williams P., Zhang L.H. A cell-cell communication signal integrates quorum sensing and stress response. Nat. Chem. Biol. 2013;9:339–343. doi: 10.1038/nchembio.1225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nchembio.1225</ArticleId>
            <ArticleId IdType="pubmed">23542643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kariminik A., Baseri-Salehi M., Kheirkhah B. Pseudomonas aeruginosa quorum sensing modulates immune responses: An updated review article. Immunol. Lett. 2017;190:1–6. doi: 10.1016/j.imlet.2017.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.imlet.2017.07.002</ArticleId>
            <ArticleId IdType="pubmed">28698104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ueda A., Wood T.K. Connecting quorum sensing, c-di-GMP, pel polysaccharide, and biofilm formation in Pseudomonas aeruginosa through tyrosine phosphatase TpbA (PA3885) PLoS Pathog. 2009;5:e1000483.  doi: 10.1371/journal.ppat.1000483.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1000483</ArticleId>
            <ArticleId IdType="pmc">PMC2691606</ArticleId>
            <ArticleId IdType="pubmed">19543378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sana T.G., Hachani A., Bucior I., Soscia C., Garvis S., Termine E., Engel J., Filloux A., Bleves S. The second type VI secretion system of Pseudomonas aeruginosa strain PAO1 is regulated by quorum sensing and Fur and modulates internalization in epithelial cells. J. Biol. Chem. 2012;287:27095–27105. doi: 10.1074/jbc.M112.376368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.376368</ArticleId>
            <ArticleId IdType="pmc">PMC3411052</ArticleId>
            <ArticleId IdType="pubmed">22665491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maura D., Hazan R., Kitao T., Ballok A.E., Rahme L.G. Evidence for Direct Control of Virulence and Defense Gene Circuits by the Pseudomonas aeruginosa Quorum Sensing Regulator, MvfR. Sci. Rep. 2016;6:34083. doi: 10.1038/srep34083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep34083</ArticleId>
            <ArticleId IdType="pmc">PMC5039717</ArticleId>
            <ArticleId IdType="pubmed">27678057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwarzer C., Ravishankar B., Patanwala M., Shuai S., Fu Z., Illek B., Fischer H., Machen T.E. Thapsigargin blocks Pseudomonas aeruginosa homoserine lactone-induced apoptosis in airway epithelia. Am. J. Physiol. Cell Physiol. 2014;306:C844–C855. doi: 10.1152/ajpcell.00002.2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00002.2014</ArticleId>
            <ArticleId IdType="pmc">PMC4010806</ArticleId>
            <ArticleId IdType="pubmed">24598360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schwarzer C., Fu Z., Patanwala M., Hum L., Lopez-Guzman M., Illek B., Kong W., Lynch S.V., Machen T.E. Pseudomonas aeruginosa biofilm-associated homoserine lactone C12 rapidly activates apoptosis in airway epithelia. Cell Microbiol. 2012;14:698–709. doi: 10.1111/j.1462-5822.2012.01753.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-5822.2012.01753.x</ArticleId>
            <ArticleId IdType="pmc">PMC4112999</ArticleId>
            <ArticleId IdType="pubmed">22233488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song D., Meng J., Cheng J., Fan Z., Chen P., Ruan H., Tu Z., Kang N., Li N., Xu Y., et al.  Pseudomonas aeruginosa quorum-sensing metabolite induces host immune cell death through cell surface lipid domain dissolution. Nat. Microbiol. 2019;4:97–111. doi: 10.1038/s41564-018-0290-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41564-018-0290-8</ArticleId>
            <ArticleId IdType="pubmed">30510173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Möker N., Dean C.R., Tao J. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J. Bacteriol. 2010;192:1946–1955. doi: 10.1128/JB.01231-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01231-09</ArticleId>
            <ArticleId IdType="pmc">PMC2838031</ArticleId>
            <ArticleId IdType="pubmed">20097861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J., Cheng J.  Quorum Sensing in Pseudomonas aeruginosa and Its Relationship to Biofilm Development. Volume 1323. American Chemical Society (USA); Washington, DC, USA: 2019. pp. 1–16.</Citation>
        </Reference>
        <Reference>
          <Citation>Bleves S., Soscia C., Nogueira-Orlandi P., Lazdunski A., Filloux A. Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAO1. J. Bacteriol. 2005;187:3898–3902. doi: 10.1128/JB.187.11.3898-3902.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.187.11.3898-3902.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1112058</ArticleId>
            <ArticleId IdType="pubmed">15901720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin J., Cheng J., Wang Y., Shen X. The Pseudomonas Quinolone Signal (PQS): Not Just for Quorum Sensing Anymore. Front. Cell Infect. Microbiol. 2018;8:230. doi: 10.3389/fcimb.2018.00230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2018.00230</ArticleId>
            <ArticleId IdType="pmc">PMC6039570</ArticleId>
            <ArticleId IdType="pubmed">30023354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García-Reyes S., Soberón-Chávez G., Cocotl-Yanez M. The third quorum-sensing system of Pseudomonas aeruginosa: Pseudomonas quinolone signal and the enigmatic PqsE protein. J. Med. Microbiol. 2020;69:25–34. doi: 10.1099/jmm.0.001116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.001116</ArticleId>
            <ArticleId IdType="pubmed">31794380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cornelis P. Putting an end to the Pseudomonas aeruginosa IQS controversy. Microbiol. Open. 2020;9:e962. doi: 10.1002/mbo3.962.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mbo3.962</ArticleId>
            <ArticleId IdType="pmc">PMC7002111</ArticleId>
            <ArticleId IdType="pubmed">31667921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J., Wang C., Yu H.B., Dela Ahator S., Wu X., Lv S., Zhang L.H. Bacterial quorum-sensing signal IQS induces host cell apoptosis by targeting POT1-p53 signalling pathway. Cell Microbiol. 2019;21:e13076. doi: 10.1111/cmi.13076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cmi.13076</ArticleId>
            <ArticleId IdType="pubmed">31254473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schick A., Kassen R. Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions. Proc. Natl. Acad. Sci. USA. 2018;115:10714–10719. doi: 10.1073/pnas.1721270115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1721270115</ArticleId>
            <ArticleId IdType="pmc">PMC6196507</ArticleId>
            <ArticleId IdType="pubmed">30275334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berical A., Lee R.E., Randell S.H., Hawkins F. Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis. Front. Pharmacol. 2019;10:74. doi: 10.3389/fphar.2019.00074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2019.00074</ArticleId>
            <ArticleId IdType="pmc">PMC6376457</ArticleId>
            <ArticleId IdType="pubmed">30800069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rossi E., La Rosa R., Bartell J.A., Marvig R.L., Haagensen J.A.J., Sommer L.M., Molin S., Johansen H.K. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat. Rev. Microbiol. 2020 doi: 10.1038/s41579-020-00477-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41579-020-00477-5</ArticleId>
            <ArticleId IdType="pubmed">33214718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhagirath A.Y., Li Y., Somayajula D., Dadashi M., Badr S., Duan K. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. BMC Pulm. Med. 2016;16:174.  doi: 10.1186/s12890-016-0339-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12890-016-0339-5</ArticleId>
            <ArticleId IdType="pmc">PMC5139081</ArticleId>
            <ArticleId IdType="pubmed">27919253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rossi G.A., Morelli P., Galietta L.J., Colin A.A. Airway microenvironment alterations and pathogen growth in cystic fibrosis. Pediatric Pulmonol. 2019;54:497–506. doi: 10.1002/ppul.24246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.24246</ArticleId>
            <ArticleId IdType="pubmed">30620146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang Y.J., LiPuma J.J. The Microbiome in Cystic Fibrosis. Clin. Chest Med. 2016;37:59–67. doi: 10.1016/j.ccm.2015.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccm.2015.10.003</ArticleId>
            <ArticleId IdType="pmc">PMC5154676</ArticleId>
            <ArticleId IdType="pubmed">26857768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beswick E., Amich J., Gago S. Factoring in the Complexity of the Cystic Fibrosis Lung to Understand Aspergillus fumigatus and Pseudomonas aeruginosa Interactions. Pathogens. 2020;9:639.  doi: 10.3390/pathogens9080639.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/pathogens9080639</ArticleId>
            <ArticleId IdType="pmc">PMC7460534</ArticleId>
            <ArticleId IdType="pubmed">32781694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams H.D., Behrends V., Bundy J.G., Ryall B., Zlosnik J.E. Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment? Front. Microbiol. 2010;1:120. doi: 10.3389/fmicb.2010.00120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2010.00120</ArticleId>
            <ArticleId IdType="pmc">PMC3109665</ArticleId>
            <ArticleId IdType="pubmed">21687721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venkatakrishnan V., Thaysen-Andersen M., Chen S.C., Nevalainen H., Packer N.H. Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype. Glycobiology. 2015;25:88–100. doi: 10.1093/glycob/cwu092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/glycob/cwu092</ArticleId>
            <ArticleId IdType="pubmed">25190359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vankeerberghen A., Cuppens H., Cassiman J.J. The cystic fibrosis transmembrane conductance regulator: An intriguing protein with pleiotropic functions. J. Cyst. Fibros. 2002;1:13–29. doi: 10.1016/S1569-1993(01)00003-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1569-1993(01)00003-0</ArticleId>
            <ArticleId IdType="pubmed">15463806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saint-Criq V., Gray M.A. Role of CFTR in epithelial physiology. Cell Mol. Life Sci. 2017;74:93–115. doi: 10.1007/s00018-016-2391-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-016-2391-y</ArticleId>
            <ArticleId IdType="pmc">PMC5209439</ArticleId>
            <ArticleId IdType="pubmed">27714410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pezzulo A.A., Tang X.X., Hoegger M.J., Abou Alaiwa M.H., Ramachandran S., Moninger T.O., Karp P.H., Wohlford-Lenane C.L., Haagsman H.P., van Eijk M., et al.  Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature. 2012;487:109–113. doi: 10.1038/nature11130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11130</ArticleId>
            <ArticleId IdType="pmc">PMC3390761</ArticleId>
            <ArticleId IdType="pubmed">22763554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erra Díaz F., Dantas E., Geffner J. Unravelling the Interplay between Extracellular Acidosis and Immune Cells. Mediat. Inflamm. 2018;2018:1218297. doi: 10.1155/2018/1218297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/1218297</ArticleId>
            <ArticleId IdType="pmc">PMC6332927</ArticleId>
            <ArticleId IdType="pubmed">30692870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Møller S.A., Jensen P., Høiby N., Ciofu O., Kragh K.N., Bjarnsholt T., Kolpen M. Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients. J. Cyst. Fibros. 2019;18:657–664. doi: 10.1016/j.jcf.2019.01.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcf.2019.01.005</ArticleId>
            <ArticleId IdType="pubmed">30711384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Riquelme S.A., Lozano C., Moustafa A.M., Liimatta K., Tomlinson K.L., Britto C., Khanal S., Gill S.K., Narechania A., Azcona-Gutiérrez J.M., et al.  CFTR-PTEN-dependent mitochondrial metabolic dysfunction promotes Pseudomonas aeruginosa airway infection. Sci. Transl. Med. 2019;11 doi: 10.1126/scitranslmed.aav4634.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.aav4634</ArticleId>
            <ArticleId IdType="pmc">PMC6784538</ArticleId>
            <ArticleId IdType="pubmed">31270271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chmiel J.F., Aksamit T.R., Chotirmall S.H., Dasenbrook E.C., Elborn J.S., LiPuma J.J., Ranganathan S.C., Waters V.J., Ratjen F.A. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann. Am. Thorac. Soc. 2014;11:1120–1129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5467101</ArticleId>
            <ArticleId IdType="pubmed">25102221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quinn R.A., Adem S., Mills R.H., Comstock W., DeRight Goldasich L., Humphrey G., Aksenov A.A., Melnik A.V., da Silva R., Ackermann G., et al.  Neutrophilic proteolysis in the cystic fibrosis lung correlates with a pathogenic microbiome. Microbiome. 2019;7:23. doi: 10.1186/s40168-019-0636-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40168-019-0636-3</ArticleId>
            <ArticleId IdType="pmc">PMC6375204</ArticleId>
            <ArticleId IdType="pubmed">30760325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guillot L., Beucher J., Tabary O., Le Rouzic P., Clement A., Corvol H. Lung disease modifier genes in cystic fibrosis. Int. J. Biochem. Cell Biol. 2014;52:83–93. doi: 10.1016/j.biocel.2014.02.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2014.02.011</ArticleId>
            <ArticleId IdType="pubmed">24569122</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Paola M., Park A.J., Ahmadi S., Roach E.J., Wu Y.S., Struder-Kypke M., Lam J.S., Bear C.E., Khursigara C.M. SLC6A14 is a genetic modifier of cystic fibrosis that regulates Pseudomonas aeruginosa attachment to human bronchial epithelial cells. mBio. 2017;8 doi: 10.1128/mBio.02073-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.02073-17</ArticleId>
            <ArticleId IdType="pmc">PMC5736915</ArticleId>
            <ArticleId IdType="pubmed">29259090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J.E., Yung R., Stefanowicz D., Shumansky K., Akhabir L., Durie P.R., Corey M., Zielenski J., Dorfman R., Daley D., et al.  Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection. Genes Immun. 2011;12:370–377. doi: 10.1038/gene.2011.5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/gene.2011.5</ArticleId>
            <ArticleId IdType="pubmed">21270830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zeitlin P.L. Cystic fibrosis and estrogens: A perfect storm. J. Clin. Investig. 2008;118:3841–3844. doi: 10.1172/JCI37778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI37778</ArticleId>
            <ArticleId IdType="pmc">PMC2582937</ArticleId>
            <ArticleId IdType="pubmed">19033654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sweezey N.B., Ratjen F. The cystic fibrosis gender gap: Potential roles of estrogen. Pediatric Pulmonol. 2014;49:309–317. doi: 10.1002/ppul.22967.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.22967</ArticleId>
            <ArticleId IdType="pubmed">24339235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saint-Criq V., Harvey B.J. Estrogen and the cystic fibrosis gender gap. Steroids. 2014;81:4–8. doi: 10.1016/j.steroids.2013.11.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.steroids.2013.11.023</ArticleId>
            <ArticleId IdType="pubmed">24342234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chotirmall S.H., Smith S.G., Gunaratnam C., Cosgrove S., Dimitrov B.D., O’Neill S.J., Harvey B.J., Greene C.M., McElvaney N.G. Effect of estrogen on Pseudomonas mucoidy and exacerbations in cystic fibrosis. N. Engl. J. Med. 2012;366:1978–1986. doi: 10.1056/NEJMoa1106126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1106126</ArticleId>
            <ArticleId IdType="pubmed">22607135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyrrell J., Harvey B.J. Sexual dimorphism in the microbiology of the CF ‘Gender Gap’: Estrogen modulation of Pseudomonas aeruginosa virulence. Steroids. 2020;156:108575. doi: 10.1016/j.steroids.2019.108575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.steroids.2019.108575</ArticleId>
            <ArticleId IdType="pubmed">31901423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Folkesson A., Jelsbak L., Yang L., Johansen H.K., Ciofu O., Høiby N., Molin S. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: An evolutionary perspective. Nat. Rev. Microbiol. 2012;10:841–851. doi: 10.1038/nrmicro2907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro2907</ArticleId>
            <ArticleId IdType="pubmed">23147702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bianconi I., Jeukens J., Freschi L., Alcalá-Franco B., Facchini M., Boyle B., Molinaro A., Kukavica-Ibrulj I., Tümmler B., Levesque R.C., et al.  Comparative genomics and biological characterization of sequential Pseudomonas aeruginosa isolates from persistent airways infection. BMC Genom. 2015;16:1105.  doi: 10.1186/s12864-015-2276-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12864-015-2276-8</ArticleId>
            <ArticleId IdType="pmc">PMC4696338</ArticleId>
            <ArticleId IdType="pubmed">26714629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cattoir V., Narasimhan G., Skurnik D., Aschard H., Roux D., Ramphal R., Jyot J., Lory S. Transcriptional response of mucoid Pseudomonas aeruginosa to human respiratory mucus. mBio. 2013;3:e00410-12. doi: 10.1128/mBio.00410-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00410-12</ArticleId>
            <ArticleId IdType="pmc">PMC3509433</ArticleId>
            <ArticleId IdType="pubmed">23143799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliver A., Mena A. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin. Microbiol. Infect. 2010;16:798–808. doi: 10.1111/j.1469-0691.2010.03250.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2010.03250.x</ArticleId>
            <ArticleId IdType="pubmed">20880409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colque C.A., Albarracín Orio A.G., Feliziani S., Marvig R.L., Tobares A.R., Johansen H.K., Molin S., Smania A.M. Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients. Antimicrob. Agents Chemother. 2020;64:e02142-19. doi: 10.1128/AAC.02142-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.02142-19</ArticleId>
            <ArticleId IdType="pmc">PMC7179616</ArticleId>
            <ArticleId IdType="pubmed">32071060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feliziani S., Marvig R.L., Luján A.M., Moyano A.J., Di Rienzo J.A., Krogh Johansen H., Molin S., Smania A.M. Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. PLoS Genet. 2014;10:e1004651.  doi: 10.1371/journal.pgen.1004651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1004651</ArticleId>
            <ArticleId IdType="pmc">PMC4199492</ArticleId>
            <ArticleId IdType="pubmed">25330091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>López-Causapé C., Rojo-Molinero E., Macià M.D., Oliver A. The problems of antibiotic resistance in cystic fibrosis and solutions. Expert Rev. Respir. Med. 2015;9:73–88. doi: 10.1586/17476348.2015.995640.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/17476348.2015.995640</ArticleId>
            <ArticleId IdType="pubmed">25541089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fothergill J.L., Walshaw M.J., Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur. Respir. J. 2012;40:227–238. doi: 10.1183/09031936.00204411.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00204411</ArticleId>
            <ArticleId IdType="pubmed">22323572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Workentine M.L., Sibley C.D., Glezerson B., Purighalla S., Norgaard-Gron J.C., Parkins M.D., Rabin H.R., Surette M.G. Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS ONE. 2013;8:e60225.  doi: 10.1371/journal.pone.0060225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0060225</ArticleId>
            <ArticleId IdType="pmc">PMC3616088</ArticleId>
            <ArticleId IdType="pubmed">23573242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Markussen T., Marvig R.L., Gómez-Lozano M., Aanæs K., Burleigh A.E., Høiby N., Johansen H.K., Molin S., Jelsbak L. Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa. mBio. 2014;5:e01592-14. doi: 10.1128/mBio.01592-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.01592-14</ArticleId>
            <ArticleId IdType="pmc">PMC4172072</ArticleId>
            <ArticleId IdType="pubmed">25227464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jorth P., Staudinger B.J., Wu X., Hisert K.B., Hayden H., Garudathri J., Harding C.L., Radey M.C., Rezayat A., Bautista G., et al.  Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs. Cell Host Microbe. 2015;18:307–319. doi: 10.1016/j.chom.2015.07.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chom.2015.07.006</ArticleId>
            <ArticleId IdType="pmc">PMC4589543</ArticleId>
            <ArticleId IdType="pubmed">26299432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malone J.G. Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs. Infect. Drug Resist. 2015;8:237–247. doi: 10.2147/IDR.S68214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IDR.S68214</ArticleId>
            <ArticleId IdType="pmc">PMC4524453</ArticleId>
            <ArticleId IdType="pubmed">26251621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harrison J.J., Almblad H., Irie Y., Wolter D.J., Eggleston H.C., Randall T.E., Kitzman J.O., Stackhouse B., Emerson J.C., Mcnamara S., et al.  Elevated exopolysaccharide levels in Pseudomonas aeruginosa flagellar mutants have implications for biofilm growth and chronic infections. PLoS Genet. 2020;16:e1008848.  doi: 10.1371/journal.pgen.1008848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1008848</ArticleId>
            <ArticleId IdType="pmc">PMC7314104</ArticleId>
            <ArticleId IdType="pubmed">32530919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pestrak M.J., Chaney S.B., Eggleston H.C., Dellos-Nolan S., Dixit S., Mathew-Steiner S.S., Roy S., Parsek M.R., Sen C.K., Wozniak D.J. Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments. PLoS Pathog. 2018;14:e1006842.  doi: 10.1371/journal.ppat.1006842.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1006842</ArticleId>
            <ArticleId IdType="pmc">PMC5812653</ArticleId>
            <ArticleId IdType="pubmed">29394295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartell J.A., Cameron D.R., Mojsoska B., Haagensen J.A.J., Pressler T., Sommer L.M., Lewis K., Molin S., Johansen H.K. Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment. PLoS Pathog. 2020;16:e1009112.  doi: 10.1371/journal.ppat.1009112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1009112</ArticleId>
            <ArticleId IdType="pmc">PMC7769609</ArticleId>
            <ArticleId IdType="pubmed">33315938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malhotra S., Hayes D., Wozniak D.J. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung. J. Cyst. Fibros. 2019;18:796–803. doi: 10.1016/j.jcf.2019.04.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcf.2019.04.009</ArticleId>
            <ArticleId IdType="pmc">PMC6815243</ArticleId>
            <ArticleId IdType="pubmed">31036488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Candido Caçador N., Paulino da Costa Capizzani C., Gomes Monteiro Marin Torres L.A., Galetti R., Ciofu O., da Costa Darini A.L., Høiby N. Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients. PLoS ONE. 2018;13:e0208013.  doi: 10.1371/journal.pone.0208013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0208013</ArticleId>
            <ArticleId IdType="pmc">PMC6264809</ArticleId>
            <ArticleId IdType="pubmed">30496246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freschi L., Bertelli C., Jeukens J., Moore M.P., Kukavica-Ibrulj I., Emond-Rheault J.G., Hamel J., Fothergill J.L., Tucker N.P., McClean S., et al.  Genomic characterisation of an international Pseudomonas aeruginosa reference panel indicates that the two major groups draw upon distinct mobile gene pools. FEMS Microbiol. Lett. 2018;365 doi: 10.1093/femsle/fny120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/femsle/fny120</ArticleId>
            <ArticleId IdType="pubmed">29897457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith D.J., Lamont I.L., Anderson G.J., Reid D.W. Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis. Eur. Respir. J. 2013;42:1723–1736. doi: 10.1183/09031936.00124012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00124012</ArticleId>
            <ArticleId IdType="pubmed">23143541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones C.J., Wozniak D.J. Psl Produced by Mucoid Pseudomonas aeruginosa Contributes to the Establishment of Biofilms and Immune Evasion. mBio. 2017;8:e00864-17. doi: 10.1128/mBio.00864-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00864-17</ArticleId>
            <ArticleId IdType="pmc">PMC5478896</ArticleId>
            <ArticleId IdType="pubmed">28634241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao J., Damron F.H., Basler M., Digiandomenico A., Sherman N.E., Fox J.W., Mekalanos J.J., Goldberg J.B. Comparisons of Two Proteomic Analyses of Non-Mucoid and Mucoid Pseudomonas aeruginosa Clinical Isolates from a Cystic Fibrosis Patient. Front. Microbiol. 2011;2:162. doi: 10.3389/fmicb.2011.00162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2011.00162</ArticleId>
            <ArticleId IdType="pmc">PMC3149151</ArticleId>
            <ArticleId IdType="pubmed">21863142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen L., Zou Y., Kronfl A.A., Wu Y. Type VI secretion system of Pseudomonas aeruginosa is associated with biofilm formation but not environmental adaptation. Microbiologyopen. 2020;9:e991. doi: 10.1002/mbo3.991.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mbo3.991</ArticleId>
            <ArticleId IdType="pmc">PMC7066461</ArticleId>
            <ArticleId IdType="pubmed">31961499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malhotra S., Limoli D.H., English A.E., Parsek M.R., Wozniak D.J. Mixed Communities of Mucoid and Nonmucoid Pseudomonas aeruginosa Exhibit Enhanced Resistance to Host Antimicrobials. mBio. 2018;9:e00275-18. doi: 10.1128/mBio.00275-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00275-18</ArticleId>
            <ArticleId IdType="pmc">PMC5874919</ArticleId>
            <ArticleId IdType="pubmed">29588399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cullen L., Weiser R., Olszak T., Maldonado R.F., Moreira A.S., Slachmuylders L., Brackman G., Paunova-Krasteva T.S., Zarnowiec P., Czerwonka G., et al.  Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: Strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains. Microbiology. 2015;161:1961–1977. doi: 10.1099/mic.0.000155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.000155</ArticleId>
            <ArticleId IdType="pubmed">26253522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cross A.R., Goldberg J.B. Remodeling of O Antigen in Mucoid Pseudomonas aeruginosa via Transcriptional Repression of wzz2. mBio. 2019;10:e02914-18. doi: 10.1128/mBio.02914-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.02914-18</ArticleId>
            <ArticleId IdType="pmc">PMC6381286</ArticleId>
            <ArticleId IdType="pubmed">30782665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Lorenzo F., Silipo A., Bianconi I., Lore N.I., Scamporrino A., Sturiale L., Garozzo D., Lanzetta R., Parrilli M., Bragonzi A., et al.  Persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73 exhibits an under-acylated LPS structure responsible of its low inflammatory activity. Mol. Immunol. 2015;63:166–175. doi: 10.1016/j.molimm.2014.04.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molimm.2014.04.004</ArticleId>
            <ArticleId IdType="pubmed">24856407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>SenGupta S., Hittle L.E., Ernst R.K., Uriarte S.M., Mitchell T.C. A Pseudomonas aeruginosa hepta-acylated lipid A variant associated with cystic fibrosis selectively activates human neutrophils. J. Leukoc. Biol. 2016;100:1047–1059. doi: 10.1189/jlb.4VMA0316-101R.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.4VMA0316-101R</ArticleId>
            <ArticleId IdType="pmc">PMC6608067</ArticleId>
            <ArticleId IdType="pubmed">27538572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tart A.H., Blanks M.J., Wozniak D.J. The AlgT-dependent transcriptional regulator AmrZ (AlgZ) inhibits flagellum biosynthesis in mucoid, nonmotile Pseudomonas aeruginosa cystic fibrosis isolates. J. Bacteriol. 2006;188:6483–6489. doi: 10.1128/JB.00636-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00636-06</ArticleId>
            <ArticleId IdType="pmc">PMC1595476</ArticleId>
            <ArticleId IdType="pubmed">16952938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolfgang M.C., Jyot J., Goodman A.L., Ramphal R., Lory S. Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients. Proc. Natl. Acad. Sci. USA. 2004;101:6664–6668. doi: 10.1073/pnas.0307553101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0307553101</ArticleId>
            <ArticleId IdType="pmc">PMC404102</ArticleId>
            <ArticleId IdType="pubmed">15084751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cigana C., Lorè N.I., Bernardini M.L., Bragonzi A. Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia. J. Biomed. Biotechnol. 2011;2011:852513. doi: 10.1155/2011/852513.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2011/852513</ArticleId>
            <ArticleId IdType="pmc">PMC3139209</ArticleId>
            <ArticleId IdType="pubmed">21785567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huus K.E., Joseph J., Zhang L., Wong A., Aaron S.D., Mah T.F., Sad S. Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail to Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation. J. Immunol. 2016;196:3097–3108. doi: 10.4049/jimmunol.1501642.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1501642</ArticleId>
            <ArticleId IdType="pubmed">26895832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jyot J., Sonawane A., Wu W., Ramphal R. Genetic mechanisms involved in the repression of flagellar assembly by Pseudomonas aeruginosa in human mucus. Mol. Microbiol. 2007;63:1026–1038. doi: 10.1111/j.1365-2958.2006.05573.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2006.05573.x</ArticleId>
            <ArticleId IdType="pubmed">17238927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Floyd M., Winn M., Cullen C., Sil P., Chassaing B., Yoo D.G., Gewirtz A.T., Goldberg J.B., McCarter L.L., Rada B. Swimming Motility Mediates the Formation of Neutrophil Extracellular Traps Induced by Flagellated Pseudomonas aeruginosa. PLoS Pathog. 2016;12:e1005987.  doi: 10.1371/journal.ppat.1005987.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1005987</ArticleId>
            <ArticleId IdType="pmc">PMC5113990</ArticleId>
            <ArticleId IdType="pubmed">27855208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amiel E., Lovewell R.R., O’Toole G.A., Hogan D.A., Berwin B. Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect. Immun. 2010;78:2937–2945. doi: 10.1128/IAI.00144-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00144-10</ArticleId>
            <ArticleId IdType="pmc">PMC2897393</ArticleId>
            <ArticleId IdType="pubmed">20457788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patankar Y.R., Lovewell R.R., Poynter M.E., Jyot J., Kazmierczak B.I., Berwin B. Flagellar motility is a key determinant of the magnitude of the inflammasome response to Pseudomonas aeruginosa. Infect. Immun. 2013;81:2043–2052. doi: 10.1128/IAI.00054-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00054-13</ArticleId>
            <ArticleId IdType="pmc">PMC3676033</ArticleId>
            <ArticleId IdType="pubmed">23529619</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang Y.S., Klockgether J., Tümmler B. An intragenic deletion in pilQ leads to nonpiliation of a Pseudomonas aeruginosa strain isolated from cystic fibrosis lung. FEMS Microbiol. Lett. 2007;270:201–206. doi: 10.1111/j.1574-6968.2007.00664.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1574-6968.2007.00664.x</ArticleId>
            <ArticleId IdType="pubmed">17302936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hogardt M., Heesemann J. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol. 2010;300:557–562. doi: 10.1016/j.ijmm.2010.08.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2010.08.008</ArticleId>
            <ArticleId IdType="pubmed">20943439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu A., Zhang M., Du W., Wang D., Ma L.Z. A molecular mechanism for how sigma factor AlgT and transcriptional regulator AmrZ inhibit twitching motility in Pseudomonas aeruginosa. Environ. Microbiol. 2020 doi: 10.1111/1462-2920.14985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1462-2920.14985</ArticleId>
            <ArticleId IdType="pubmed">32162778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu W., Badrane H., Arora S., Baker H.V., Jin S. MucA-mediated coordination of type III secretion and alginate synthesis in Pseudomonas aeruginosa. J. Bacteriol. 2004;186:7575–7585. doi: 10.1128/JB.186.22.7575-7585.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.186.22.7575-7585.2004</ArticleId>
            <ArticleId IdType="pmc">PMC524895</ArticleId>
            <ArticleId IdType="pubmed">15516570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Intile P.J., Diaz M.R., Urbanowski M.L., Wolfgang M.C., Yahr T.L. The AlgZR two-component system recalibrates the RsmAYZ posttranscriptional regulatory system to inhibit expression of the Pseudomonas aeruginosa type III secretion system. J. Bacteriol. 2014;196:357–366. doi: 10.1128/JB.01199-13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01199-13</ArticleId>
            <ArticleId IdType="pmc">PMC3911257</ArticleId>
            <ArticleId IdType="pubmed">24187093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryall B., Carrara M., Zlosnik J.E., Behrends V., Lee X., Wong Z., Lougheed K.E., Williams H.D. The mucoid switch in Pseudomonas aeruginosa represses quorum sensing systems and leads to complex changes to stationary phase virulence factor regulation. PLoS ONE. 2014;9:e96166.  doi: 10.1371/journal.pone.0096166.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0096166</ArticleId>
            <ArticleId IdType="pmc">PMC4031085</ArticleId>
            <ArticleId IdType="pubmed">24852379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mehta H.H., Prater A.G., Beabout K., Elworth R.A.L., Karavis M., Gibbons H.S., Shamoo Y. The Essential Role of Hypermutation in Rapid Adaptation to Antibiotic Stress. Antimicrob. Agents Chemother. 2019;63:e00744-19. doi: 10.1128/AAC.00744-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00744-19</ArticleId>
            <ArticleId IdType="pmc">PMC6591599</ArticleId>
            <ArticleId IdType="pubmed">31036684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D’Argenio D.A., Wu M., Hoffman L.R., Kulasekara H.D., Déziel E., Smith E.E., Nguyen H., Ernst R.K., Larson Freeman T.J., Spencer D.H., et al.  Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol. Microbiol. 2007;64:512–533. doi: 10.1111/j.1365-2958.2007.05678.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2007.05678.x</ArticleId>
            <ArticleId IdType="pmc">PMC2742308</ArticleId>
            <ArticleId IdType="pubmed">17493132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman L.R., Kulasekara H.D., Emerson J., Houston L.S., Burns J.L., Ramsey B.W., Miller S.I. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J. Cyst. Fibros. 2009;8:66–70. doi: 10.1016/j.jcf.2008.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcf.2008.09.006</ArticleId>
            <ArticleId IdType="pmc">PMC2631641</ArticleId>
            <ArticleId IdType="pubmed">18974024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiricny N., Molin S., Foster K., Diggle S.P., Scanlan P.D., Ghoul M., Johansen H.K., Santorelli L.A., Popat R., West S.A., et al.  Loss of social behaviours in populations of Pseudomonas aeruginosa infecting lungs of patients with cystic fibrosis. PLoS ONE. 2014;9:e83124.  doi: 10.1371/journal.pone.0083124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0083124</ArticleId>
            <ArticleId IdType="pmc">PMC3891558</ArticleId>
            <ArticleId IdType="pubmed">24454693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>LaFayette S.L., Houle D., Beaudoin T., Wojewodka G., Radzioch D., Hoffman L.R., Burns J.L., Dandekar A.A., Smalley N.E., Chandler J.R., et al.  Cystic fibrosis–adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses. Sci. Adv. 2015;1:e1500199. doi: 10.1126/sciadv.1500199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/sciadv.1500199</ArticleId>
            <ArticleId IdType="pmc">PMC4597794</ArticleId>
            <ArticleId IdType="pubmed">26457326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Rosa R., Johansen H.K., Molin S. Adapting to the Airways: Metabolic Requirements of Pseudomonas aeruginosa during the Infection of Cystic Fibrosis Patients. Metabolites. 2019;9:234.  doi: 10.3390/metabo9100234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/metabo9100234</ArticleId>
            <ArticleId IdType="pmc">PMC6835255</ArticleId>
            <ArticleId IdType="pubmed">31623245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar S.S., Penesyan A., Elbourne L.D.H., Gillings M.R., Paulsen I.T. Catabolism of Nucleic Acids by a Cystic Fibrosis Pseudomonas aeruginosa Isolate: An adaptive pathway to cystic fibrosis sputum environment. Front. Microbiol. 2019;10:1199. doi: 10.3389/fmicb.2019.01199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2019.01199</ArticleId>
            <ArticleId IdType="pmc">PMC6555301</ArticleId>
            <ArticleId IdType="pubmed">31214142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marvig R.L., Damkiær S., Khademi S.M., Markussen T.M., Molin S., Jelsbak L. Within-host evolution of Pseudomonas aeruginosa reveals adaptation toward iron acquisition from hemoglobin. mBio. 2014;5:e00966-14. doi: 10.1128/mBio.00966-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00966-14</ArticleId>
            <ArticleId IdType="pmc">PMC4010824</ArticleId>
            <ArticleId IdType="pubmed">24803516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dingemans J., Ye L., Hildebrand F., Tontodonati F., Craggs M., Bilocq F., De Vos D., Crabbé A., Van Houdt R., Malfroot A., et al.  The deletion of TonB-dependent receptor genes is part of the genome reduction process that occurs during adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung. Pathog. Dis. 2014;71:26–38. doi: 10.1111/2049-632X.12170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/2049-632X.12170</ArticleId>
            <ArticleId IdType="pubmed">24659602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bianconi I., D’Arcangelo S., Esposito A., Benedet M., Piffer E., Dinnella G., Gualdi P., Schinella M., Baldo E., Donati C., et al.  Persistence and Microevolution of Pseudomonas aeruginosa in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study. Front. Microbiol. 2018;9:3242. doi: 10.3389/fmicb.2018.03242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmicb.2018.03242</ArticleId>
            <ArticleId IdType="pmc">PMC6340092</ArticleId>
            <ArticleId IdType="pubmed">30692969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Llanes C., Pourcel C., Richardot C., Plésiat P., Fichant G., Cavallo J.D., Mérens A., Group G.S. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: A French multicentre study. J. Antimicrob. Chemother. 2013;68:1763–17671. doi: 10.1093/jac/dkt115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/dkt115</ArticleId>
            <ArticleId IdType="pubmed">23629014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castanheira M., Mills J.C., Farrell D.J., Jones R.N. Mutation-driven β-lactam resistance mechanisms among contemporary ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates from U.S. hospitals. Antimicrob. Agents Chemother. 2014;58:6844–6850. doi: 10.1128/AAC.03681-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.03681-14</ArticleId>
            <ArticleId IdType="pmc">PMC4249397</ArticleId>
            <ArticleId IdType="pubmed">25182652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varga J.J., Barbier M., Mulet X., Bielecki P., Bartell J.A., Owings J.P., Martinez-Ramos I., Hittle L.E., Davis M.R., Damron F.H., et al.  Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains. BMC Genom. 2015;16:883.  doi: 10.1186/s12864-015-2069-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12864-015-2069-0</ArticleId>
            <ArticleId IdType="pmc">PMC4628258</ArticleId>
            <ArticleId IdType="pubmed">26519161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt K.D., Tümmler B., Römling U. Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J. Bacteriol. 1996;178:85–93. doi: 10.1128/JB.178.1.85-93.1996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.178.1.85-93.1996</ArticleId>
            <ArticleId IdType="pmc">PMC177624</ArticleId>
            <ArticleId IdType="pubmed">8550447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mielko K.A., Jabłoński S.J., Milczewska J., Sands D., Łukaszewicz M., Młynarz P. Metabolomic studies of Pseudomonas aeruginosa. World J. Microbiol. Biotechnol. 2019;35:178. doi: 10.1007/s11274-019-2739-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11274-019-2739-1</ArticleId>
            <ArticleId IdType="pmc">PMC6838043</ArticleId>
            <ArticleId IdType="pubmed">31701321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parkins M.D., Somayaji R., Waters V.J. Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis. Clin. Microbiol. Rev. 2018;31 doi: 10.1128/CMR.00019-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.00019-18</ArticleId>
            <ArticleId IdType="pmc">PMC6148191</ArticleId>
            <ArticleId IdType="pubmed">30158299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winsor G.L., Griffiths E.J., Lo R., Dhillon B.K., Shay J.A., Brinkman F.S. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res. 2016;44:D646–D653. doi: 10.1093/nar/gkv1227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkv1227</ArticleId>
            <ArticleId IdType="pmc">PMC4702867</ArticleId>
            <ArticleId IdType="pubmed">26578582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romero P., Karp P. PseudoCyc, a pathway-genome database for Pseudomonas aeruginosa. J. Mol. Microbiol. Biotechnol. 2003;5:230–239. doi: 10.1159/000071075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000071075</ArticleId>
            <ArticleId IdType="pubmed">12867747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi C., Münch R., Leupold S., Klein J., Siegel I., Thielen B., Benkert B., Kucklick M., Schobert M., Barthelmes J., et al.  SYSTOMONAS--an integrated database for systems biology analysis of Pseudomonas. Nucleic Acids Res. 2007;35:D533–D537. doi: 10.1093/nar/gkl823.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkl823</ArticleId>
            <ArticleId IdType="pmc">PMC1899106</ArticleId>
            <ArticleId IdType="pubmed">17202169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanehisa M., Furumichi M., Tanabe M., Sato Y., Morishima K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353–D361. doi: 10.1093/nar/gkw1092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkw1092</ArticleId>
            <ArticleId IdType="pmc">PMC5210567</ArticleId>
            <ArticleId IdType="pubmed">27899662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S., Thiessen P.A., Bolton E.E., Chen J., Fu G., Gindulyte A., Han L., He J., He S., Shoemaker B.A., et al.  PubChem Substance and Compound databases. Nucleic Acids Res. 2016;44:D1202–D1213. doi: 10.1093/nar/gkv951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkv951</ArticleId>
            <ArticleId IdType="pmc">PMC4702940</ArticleId>
            <ArticleId IdType="pubmed">26400175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wishart D.S., Jewison T., Guo A.C., Wilson M., Knox C., Liu Y., Djoumbou Y., Mandal R., Aziat F., Dong E., et al.  HMDB 3.0—The Human Metabolome Database in 2013. Nucleic Acids Res. 2013;41:D801–D807. doi: 10.1093/nar/gks1065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gks1065</ArticleId>
            <ArticleId IdType="pmc">PMC3531200</ArticleId>
            <ArticleId IdType="pubmed">23161693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marvig R.L., Sommer L.M., Molin S., Johansen H.K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat. Genet. 2015;47:57–64. doi: 10.1038/ng.3148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.3148</ArticleId>
            <ArticleId IdType="pubmed">25401299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greipel L., Fischer S., Klockgether J., Dorda M., Mielke S., Wiehlmann L., Cramer N., Tümmler B. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients. Antimicrob. Agents Chemother. 2016;60:6726–6734. doi: 10.1128/AAC.00724-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00724-16</ArticleId>
            <ArticleId IdType="pmc">PMC5075079</ArticleId>
            <ArticleId IdType="pubmed">27572404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmed M.N., Abdelsamad A., Wassermann T., Porse A., Becker J., Sommer M.O.A., Høiby N., Ciofu O. The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: Beyond selection of antibiotic resistance. NPJ Biofilms Microbiomes. 2020;6:28. doi: 10.1038/s41522-020-00138-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41522-020-00138-8</ArticleId>
            <ArticleId IdType="pmc">PMC7381665</ArticleId>
            <ArticleId IdType="pubmed">32709907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Rosa R., Johansen H.K., Molin S. Convergent Metabolic Specialization through Distinct Evolutionary Paths in Pseudomonas aeruginosa. mBio. 2018;9 doi: 10.1128/mBio.00269-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00269-18</ArticleId>
            <ArticleId IdType="pmc">PMC5893872</ArticleId>
            <ArticleId IdType="pubmed">29636437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martínez-Carranza E., García-Reyes S., González-Valdez A., Soberón-Chávez G. Tracking the genome of four Pseudomonas aeruginosa isolates that have a defective Las quorum-sensing system, but are still virulent. Access Microbiol. 2020;2:acmi000132. doi: 10.1099/acmi.0.000132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/acmi.0.000132</ArticleId>
            <ArticleId IdType="pmc">PMC7497837</ArticleId>
            <ArticleId IdType="pubmed">32974595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartell J.A., Sommer L.M., Haagensen J.A.J., Loch A., Espinosa R., Molin S., Johansen H.K. Evolutionary highways to persistent bacterial infection. Nat. Commun. 2019;10:629. doi: 10.1038/s41467-019-08504-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-019-08504-7</ArticleId>
            <ArticleId IdType="pmc">PMC6367392</ArticleId>
            <ArticleId IdType="pubmed">30733448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams D., Evans B., Haldenby S., Walshaw M.J., Brockhurst M.A., Winstanley C., Paterson S. Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections. Am. J. Respir. Crit. Care Med. 2015;191:775–785. doi: 10.1164/rccm.201409-1646OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201409-1646OC</ArticleId>
            <ArticleId IdType="pmc">PMC4407486</ArticleId>
            <ArticleId IdType="pubmed">25590983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cramer N., Klockgether J., Wrasman K., Schmidt M., Davenport C.F., Tümmler B. Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ. Microbiol. 2011;13:1690–1704. doi: 10.1111/j.1462-2920.2011.02483.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1462-2920.2011.02483.x</ArticleId>
            <ArticleId IdType="pubmed">21492363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grothues D., Koopmann U., von der Hardt H., Tümmler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J. Clin. Microbiol. 1988;26:1973–1977. doi: 10.1128/JCM.26.10.1973-1977.1988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.26.10.1973-1977.1988</ArticleId>
            <ArticleId IdType="pmc">PMC266800</ArticleId>
            <ArticleId IdType="pubmed">3141456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomassen M.J., Demko C.A., Doershuk C.F., Root J.M. Pseudomonas aeruginosa isolates: Comparisons of isolates from campers and from sibling pairs with cystic fibrosis. Pediatr Pulmonol. 1985;1:40–45. doi: 10.1002/ppul.1950010110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ppul.1950010110</ArticleId>
            <ArticleId IdType="pubmed">3932947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolz C., Kiosz G., Ogle J.W., Vasil M.L., Schaad U., Botzenhart K., Döring G. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe. Epidemiol. Infect. 1989;102:205–214. doi: 10.1017/S0950268800029873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0950268800029873</ArticleId>
            <ArticleId IdType="pmc">PMC2249438</ArticleId>
            <ArticleId IdType="pubmed">2495226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedersen S.S., Jensen T., Pressler T., Høiby N., Rosendal K. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection? Acta Paediatr Scand. 1986;75:840–845. doi: 10.1111/j.1651-2227.1986.tb10299.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1651-2227.1986.tb10299.x</ArticleId>
            <ArticleId IdType="pubmed">3105236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedersen S.S., Koch C., Høiby N., Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J. Antimicrob. Chemother. 1986;17:505–516. doi: 10.1093/jac/17.4.505.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jac/17.4.505</ArticleId>
            <ArticleId IdType="pubmed">3086274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng K., Smyth R.L., Govan J.R., Doherty C., Winstanley C., Denning N., Heaf D.P., van Saene H., Hart C.A. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet. 1996;348:639–642. doi: 10.1016/S0140-6736(96)05169-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(96)05169-0</ArticleId>
            <ArticleId IdType="pubmed">8782753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu H., Harmer C., Anuj S., Wainwright C.E., Manos J., Cheney J., Harbour C., Zablotska I., Turnbull L., Whitchurch C.B., et al.  Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening. Clin. Microbiol. Infect. 2013;19:266–272. doi: 10.1111/j.1469-0691.2012.03770.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2012.03770.x</ArticleId>
            <ArticleId IdType="pubmed">22329595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kidd T.J., Ramsay K.A., Vidmar S., Carlin J.B., Bell S.C., Wainwright C.E., Grimwood K., Investigators A.S. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years. J. Cyst. Fibros. 2015;14:361–369. doi: 10.1016/j.jcf.2014.12.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcf.2014.12.007</ArticleId>
            <ArticleId IdType="pubmed">25563522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ranganathan S.C., Skoric B., Ramsay K.A., Carzino R., Gibson A.M., Hart E., Harrison J., Bell S.C., Kidd T.J. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis. Ann. Am. Thorac. Soc. 2013;10:108–114. doi: 10.1513/AnnalsATS.201209-077OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1513/AnnalsATS.201209-077OC</ArticleId>
            <ArticleId IdType="pubmed">23607838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fluge G., Ojeniyi B., Høiby N., Digranes A., Ciofu O., Hunstad E., Haanaes O.C., Storrøsten O.T. Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin. Microbiol. Infect. 2001;7:238–243. doi: 10.1046/j.1469-0691.2001.00247.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1469-0691.2001.00247.x</ArticleId>
            <ArticleId IdType="pubmed">11422250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmid J., Ling L.J., Leung J.L., Zhang N., Kolbe J., Wesley A.W., Mills G.D., Brown P.J., Jones D.T., Laing R.T., et al.  Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics. Eur. Respir. J. 2008;32:1583–1590. doi: 10.1183/09031936.00099508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00099508</ArticleId>
            <ArticleId IdType="pubmed">18715877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Daele S., Vaneechoutte M., De Boeck K., Knoop C., Malfroot A., Lebecque P., Leclercq-Foucart J., Van Schil L., Desager K., De Baets F. Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients. Eur. Respir. J. 2006;28:740–747. doi: 10.1183/09031936.06.00002706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.06.00002706</ArticleId>
            <ArticleId IdType="pubmed">16774955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashish A., Paterson S., Mowat E., Fothergill J.L., Walshaw M.J., Winstanley C. Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis. J. Cyst. Fibros. 2013;12:790–793. doi: 10.1016/j.jcf.2013.04.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcf.2013.04.003</ArticleId>
            <ArticleId IdType="pmc">PMC3851688</ArticleId>
            <ArticleId IdType="pubmed">23642644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tingpej P., Smith L., Rose B., Zhu H., Conibear T., Al Nassafi K., Manos J., Elkins M., Bye P., Willcox M., et al.  Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J. Clin. Microbiol. 2007;45:1697–1704. doi: 10.1128/JCM.02364-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.02364-06</ArticleId>
            <ArticleId IdType="pmc">PMC1933084</ArticleId>
            <ArticleId IdType="pubmed">17392437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ciofu O., Mandsberg L.F., Bjarnsholt T., Wassermann T., Høiby N. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: Strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology. 2010;156:1108–1119. doi: 10.1099/mic.0.033993-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.033993-0</ArticleId>
            <ArticleId IdType="pubmed">20019078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sokurenko E.V., Hasty D.L., Dykhuizen D.E. Pathoadaptive mutations: Gene loss and variation in bacterial pathogens. Trends Microbiol. 1999;7:191–195. doi: 10.1016/S0966-842X(99)01493-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0966-842X(99)01493-6</ArticleId>
            <ArticleId IdType="pubmed">10354593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanz-García F., Hernando-Amado S., Martínez J.L. Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either. Ceftazidime or Ceftazidime-Avibactam. Antimicrob. Agents Chemother. 2018;62 doi: 10.1128/AAC.01379-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.01379-18</ArticleId>
            <ArticleId IdType="pmc">PMC6153820</ArticleId>
            <ArticleId IdType="pubmed">30082283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodríguez-Rojas A., Mena A., Martín S., Borrell N., Oliver A., Blázquez J. Inactivation of the hmgA gene of Pseudomonas aeruginosa leads to pyomelanin hyperproduction, stress resistance and increased persistence in chronic lung infection. Microbiology. 2009;155:1050–1057. doi: 10.1099/mic.0.024745-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mic.0.024745-0</ArticleId>
            <ArticleId IdType="pubmed">19332807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarez-Ortega C., Wiegand I., Olivares J., Hancock R.E., Martínez J.L. Genetic determinants involved in the susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Antimicrob. Agents Chemother. 2010;54:4159–4167. doi: 10.1128/AAC.00257-10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00257-10</ArticleId>
            <ArticleId IdType="pmc">PMC2944606</ArticleId>
            <ArticleId IdType="pubmed">20679510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuda N., Sakagawa E., Ohya S., Gotoh N., Tsujimoto H., Nishino T. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2000;44:2242–2246. doi: 10.1128/AAC.44.9.2242-2246.2000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.44.9.2242-2246.2000</ArticleId>
            <ArticleId IdType="pmc">PMC90052</ArticleId>
            <ArticleId IdType="pubmed">10952562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oakley J.L., Weiser R., Powell L.C., Forton J., Mahenthiralingam E., Rye P.D., Hill K.E., Thomas D.W., Pritchard M.F. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy. mSphere. 2021;6 doi: 10.1128/mSphere.01216-20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mSphere.01216-20</ArticleId>
            <ArticleId IdType="pmc">PMC7845618</ArticleId>
            <ArticleId IdType="pubmed">33472983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flynn K.M., Dowell G., Johnson T.M., Koestler B.J., Waters C.M., Cooper V.S. Evolution of Ecological Diversity in Biofilms of Pseudomonas aeruginosa by Altered Cyclic Diguanylate Signaling. J. Bacteriol. 2016;198:2608–2618. doi: 10.1128/JB.00048-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.00048-16</ArticleId>
            <ArticleId IdType="pmc">PMC5019052</ArticleId>
            <ArticleId IdType="pubmed">27021563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vanderwoude J., Fleming D., Azimi S., Trivedi U., Rumbaugh K.P., Diggle S.P. The evolution of virulence in Pseudomonas aeruginosa during chronic wound infection. Proc. Biol. Sci. 2020;287:20202272. doi: 10.1098/rspb.2020.2272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1098/rspb.2020.2272</ArticleId>
            <ArticleId IdType="pmc">PMC7661302</ArticleId>
            <ArticleId IdType="pubmed">33081616</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
